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Background: Cryptococcal induced visual loss is common and increasingly becoming a 
debilitating consequence in survivors of cryptococcal meningitis (CM). Conflicting reports of 
the optic neuritis and papilloedema models of visual loss have delayed the introduction of 
effective interventional strategies for prevention and treatment of visual loss in CM. 
Qualitative and quantitative diffusion-weighted imaging (DWI) and diffusion tensor imaging 
(DTI) of the optic nerves have proven useful in the examination of the microstructure of the 
optic nerve especially in optic neuritis. Its application has been extrapolated to other optic 
nerve disorders such as ischaemic optic neuropathy and glaucoma. The aim of this study is to 
elucidate the pathogenesis of cryptococcal-induced visual loss using diffusion imaging of the 
optic nerve as an investigational tool.  
Method: Full ethical approval was obtained from the Greys Hospital, Department of Health 
and University of KwaZulu Natal Ethics Committees. Reliable and reproducible optic nerve 
diffusion techniques were first developed and optimized on 29 healthy volunteers at Greys 
Hospital, Neurology and Radiology departments using a Philips 1.5 Tesla Gyroscan. 
Informed consent was also obtained from 95 patients suffering from CM (≥18 yrs. of age), 14 
patients with papilloedema and 14 patients with optic neuritis from other causes, recruited 
from Greys and Edendale Hospitals. Patients underwent full neuro-ophthalmological 
assessments, CSF examination, haematological workup, CD4 count, (viral load for some), 
electrophysiological assessment of vision [Visual evoked potential (VEP) and Humphreys 
visual fields (HVF)], Magnetic Resonance Imaging (MRI) scan of the brain and orbits and 
DWI and DTI of the optic nerves.  
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Results and Discussion: Visual loss is common in CM, occurring in 34.6-48%. Optic 
neuritis was uncommon as evidenced by a lack of signal change and lack of enhancement 
within the optic nerve in all patients scanned. The peri-optic CSF space was not dilated and 
the optic nerve diameter was not increased regardless of CSF pressure and visual status. 
Swollen optic discs occurred in only 25% of patients whereas raised intracranial pressure (> 
20cmCSF) was demonstrated in 69-71% of patients. Therefore visual loss could not be 
explained by papilloedema alone. The VEP P100 latency was shown to be a useful screening 
test for subclinical optic nerve disease in CM, but HVF was not.  
The optic nerve diffusion imaging used was reliable and reproducible and produced diffusion 
parameters equivalent to other investigators in the field. Neither optic nerve movement nor 
the CSF signal was demonstrated to impact significantly on optic nerve diffusion parameters. 
Optic nerve diffusion imaging did not demonstrate similarities between CM and 
papilloedema or optic neuritis regardless of CSF pressure or vision.  
Conclusion: The rarity of optic neuritis in CM and the disparity between papilloedema and 
visual loss together with the lack of support from diffusion studies suggest a 3rd mechanism 
of visual loss viz. the optic nerve compartment syndrome. Good clinical support is provided 
by a case report for this hypothesis that shows re-opening of the peri-optic CSF space and 
return of the peri-optic CSF signal on MRI with lowering of intracranial pressure and 
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CHAPTER 1  INTRODUCTION 
In developing countries, cryptococcal meningitis (CM) is a common opportunistic infection 
in severely immunocompromised human immunodeficiency virus (HIV) - infected patients 
[1]. In South Africa, the antiretroviral (ARV) rollout program has not yet had an impact on 
the incidence of CM due to limited access to ARV rollout sites, poor compliance and 
restrictions imposed on the number of patients eligible for treatment [2-4]. The result is that 
CM presents as an AIDS - defining illness in 5-10% of patients and in 50% of these patients, 
with neurological complications (visual loss, cranial nerve palsies such as 6th , 7th and 8th, 
papilloedema, depressed level of consciousness) [5, 6]. One such devastating complication 
viz. visual loss from optic nerve disease is reported in 35- 52.6% of patients with CM [3, 7, 
8]. Visual loss continues to progress in 17.3% despite antifungal therapy and in 3.7% of 
patients follows commencement of antifungal therapy [9]. So despite antifungal therapy 
vision may continue to deteriorate and recovery is unpredictable. Early and effective 
adjunctive therapy is therefore of paramount importance to prevent or reverse the frequent 
and sometimes catastrophic loss of vision.  
Effective interventional therapy can only be advocated when the pathophysiology of vision 
loss in CM is well understood. Unfortunately, there are conflicting reports regarding its 
pathophysiology and standard treatment protocols are disappointingly lacking. The landmark 
study by Rex et al in 1993 proposed 2 main pathophysiological mechanisms viz. early optic 
neuritis and late papilloedema [10]. 
The inflammatory (optic neuritis) model was supported by work done by various authors. 
Seaton et al in 1997 showed visual improvement with corticosteroid therapy in cryptococcal 
induced vision loss suggesting the benefit of its anti-inflammatory action [11]. Their patients 
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were immunocompetent and infected with Cryptococcus gattii. The inflammatory response 
was therefore excessive and response to steroids understandable. Cohen et al in 1993 showed 
histopathologically the findings of active inflammation and necrosis of the optic nerve 
without vascular infiltration but florid infiltration of the surrounding meninges by the 
cryptococcal organism [12]. Such evidence for nerve infiltration was irrefutable. Lipson BK’s 
visual field work and demonstration of centrocaecal scotomata was also overwhelming 
evidence of primary optic nerve pathology [13]. On the other hand, the raised intracranial 
pressure (papilloedema) model was suggested by various reports of the beneficial response to 
lowering of intracranial pressure either by serial lumbar punctures, ventriculoperitoneal 
shunts, lumbar drains, lumbar peritoneal shunts or optic nerve sheath fenestration on 
cryptococcal induced vision loss [14-18]. The co-occurrence of raised intracranial pressure in 
cryptococcal meningitis is well documented. The pathophysiology of which is most likely 
due to plugging of the arachnoid granulations by whole cryptococci and fragments of the 
polysaccharide capsule which Loyse et al have pathologically demonstrated [19].  
The mechanism by which patients with cryptococcal meningitis develop visual loss continues 
to be unclear with anecdotal evidence supporting opposing theories of papilloedema and optic 
neuritis. These theories may not be mutually exclusive and a mechanism that incorporates 
both theories is conceivable. The possibility of a third mechanism, viz. the compartment 
syndrome also needs exploration and in this study evidence for such a mechanism will be 
presented. Pathological studies are scanty and can be misleading due to the loss of the effects 
of raised pressure on the optic nerves post mortem. An in vivo study that investigates the 




Diffusion weighted imaging (DWI) and Diffusion tensor imaging (DTI) of the optic nerve 
has been shown to be of benefit in imaging the microstructure of the optic nerve and 
detecting pathology at a microscopic level. Most recent studies have involved demonstrating 
the effects of acute and chronic optic neuritis in multiple sclerosis [20-23]. Additional use for 
this investigational tool has been in disorders such as acute ischaemic optic neuropathy and 
glaucoma [24, 25]. The apparent diffusion coefficient (ADC) varies with direction if the 
diffusion is anisotropic. Mean diffusivity (MD) is a scalar index of diffusion that can be 
reported in the different orthogonal axes [26]. Both qualitative mapping and quantitative data 
can be obtained on diffusion imaging [27].  
Diffusion of protons within optic nerves is anisotropic due to the orientation of fibres. Hence 
diffusion that occurs parallel to the axons is greater than that which occurs perpendicular 
[28]. This parallel to perpendicular ratio is dependent on the presence of intact myelin and 
axons.  Where disruption of the myelin and axons occur as with inflammation of the optic 
nerve, demyelination and secondary axonal degeneration occur resulting in the optic nerve 
becoming less anisotropic or more isotropic. The Fractional anisotropy (FA) and anisotropic 
index (AI) are indices of anisotropy that are measured on DTI and DWI and are lowered in 
diseases that disrupt the integrity of the optic nerve [29]. 
 
In optic neuritis, there is perivascular lymphocytic infiltration, multifocal demyelination, and 
reactive astrocytosis [30]. Various authors have demonstrated increased ADC and increased 
MD and decreased FA in chronic optic neuritis due to myelin and axonal loss [20-23]. In 
acute optic neuritis due to the intact axon cylinders diffusion in the parallel direction 
(axial/longitudinal) is decreased or unaffected but perpendicular (radial) diffusion increases. 
One may hypothesize a similar diffusion abnormality in acute optic neuritis to that of the 
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optic nerves in cryptococcal induced visual loss if the predominant disorder is optic nerve 
infiltration. In the optic neuritis model of CM, the ADC and MD values along the parallel 
plane will be decreased and FA values will also be reduced due to the presence of 
inflammatory cells and fungi within the optic nerve that disrupt optic nerve microstructure. 
The mean ADC and MD will be decreased in the parallel axis. One may also expect a 
decrease in the parallel (axial) to perpendicular (radial) diffusion ratios such as the AI due to 
greater isotropic diffusion.  
In papilloedema from any cause of elevated intracranial pressure, disc swelling results from 
axoplasmic flow stasis [7]. There is entrapment of the optic nerve axons at the lamina 
cribrosa due to elevated intracranial pressure transmitted along the subarachnoid space to the 
junction of the globe and retrobulbar optic nerve. Axoplasm and metabolic products 
accumulate at the optic disc resulting in hyperaemia and elevation of the disc [31]. The 
retrobulbar optic nerve is structurally normal in papilloedema but little is known about its 
functional status. In any liquid medium, diffusion of molecules is dependent on the thermal 
energy of the medium. When thermal energy increases, there is increased kinetic energy and 
increased diffusion of molecules. Therefore one may speculate that the effect of elevated 
pressure on the optic nerve as occurs in papilloedema, will result in increased thermal motion 
of the water molecules and therefore increased diffusion in the parallel axis along the intact 
axons. Higher ADC values will occur more in the parallel than perpendicular direction. The 
ratio of parallel (axial) to perpendicular (radial) diffusion should be higher since diffusion 
will be increased in the parallel/longitudinal axis. AI should be higher.  One may also 
speculate that the FA along the optic nerve should be higher. 
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Hence, DWI and DTI could theoretically be useful measuring instruments to differentiate 
between the effects of raised pressure and infiltration on optic nerve functioning. The 
possibility of dual mechanisms will also be entertained and explored.  
The aim of this study was to investigate the pathogenesis of cryptococcal induced visual loss 
by the use of DWI and DTI in vivo. The initial goal was to clinically and 
electrophysiologically describe visual loss in patients with cryptococcal meningitis. 
Concurrently, the techniques of DWI and DTI of the optic nerve were optimized and made 
reproducible for reliable testing of subjects and controls. Techniques that have already been 
employed were modified to accommodate the restricted resources available and imaging of 
mildly encephalopathic patients [32-34]. The modifiable parameters that were considered 
were the amount of eye movement, fat suppression, fluid attenuation, ‘b’ values etc to 
optimize signal to noise ratio (SNR).  
Comparisons were made to normal controls, patients without visual loss, and to patients with 
pathophysiologically established causes of papilloedema and optic neuritis with the goal of 
confirming or refuting the optic neuritis and papilloedema models. Early recognition and 
prevention of blindness in survivors of CM are the primary objective of this study. The 
results will show that visual loss in CM is common and electrophysiological testing will 
confirm subclinical disease. The possibility of a compartment syndrome at the optic canal 
level, secondary to raised intracranial pressure will be discussed and evidence presented to 






CHAPTER 2 LITERATURE REVIEW 
2.1 Cryptococcal meningitis 
 Meningitis caused by Cryptococcus neoformans continues to be a common HIV related 
opportunistic infection in developing countries, largely due to the unavailability of anti-
retroviral therapy and poor compliance when available[1, 2, 6, 35]. A CD4 count of <100 
cells/µL predisposes to CM [36, 37]. Patients present with subacute onset of fever, 
headaches, altered mental state, malaise, nausea, vomiting and photophobia followed by 
diplopia which is usually from 6th nerve palsies [38]. The headaches are due to raised 
intracranial pressure and are worse when lying down, are aggravated by Valsalva maneuvers 
and awaken the patient in the early hours of the morning when severity is worst.[5] Typical 
signs of meningitis are usually evident at presentation and papilloedema is a common clinical 
finding on eye examination. The 6th nerve palsies result from raised intracranial pressure (> 
20cmCSF) as false localizing signs rather than from ischaemia or inflammation. 
The cerebrospinal fluid (CSF) findings of CM include elevated pressure, paucity of 
inflammatory cells, low CSF glucose and elevated CSF protein. India ink staining is positive 
in 60% of patients and cryptococcal antigen in >99% of patients [38, 39]. While the gold 
standard is fungal culture, most clinicians rely on the clinical findings, India ink stain and 
cryptococcal antigen to make the diagnosis. Induction therapy includes intravenous 
amphotericin B at 0.7 – 1 mg/kg/d plus oral flucytosine (100mg/kg/d) for the first 2 weeks. 
Where flucytosine is not available, amphotericin B in combination with fluconazole 800mg/d 
is found to be adequate as induction therapy as recommended by World Health Organisation 
(WHO) guidelines in 2011 and  [40]. Consolidation therapy follows with oral Fluconazole 
400mg – 800mg daily for 8 weeks or until the CSF becomes sterile [38]. Fluconazole is 
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thereafter continued as maintenance therapy at 200mg daily for life in HIV infected patients 
or until there is immune reconstitution of CD4 count > 200cells/µL for 12 months. 
2.2 Epidemiology of Cryptococcal meningitis in South Africa and other developing 
countries 
While the incidence of CM has declined in developed countries, it continues to be a major 
opportunistic infection in HIV-infected patients in developing countries [1-3]. CM accounts 
for 26.5% of cases in a series from Malawi [41], 31% of cases in a series from Central 
African Republic [42]and 45% from Zimbabwe [43].   CM accounts for 13-44% of all deaths 
in HIV-infected patients [36, 44, 45]. Moosa et al have shown neurological complications in 
50% of their cases with mortality as high as 64% for in-patients [6].  Late presentation for 
treatment, poor compliance and the lack of anti-fungal and anti-retroviral therapy are reasons 
for the poorer prognosis in developing countries [46]. A median survival of 19 days is quoted 
in a Zambian case series recruited in the pre-ARV era with low dose fluconazole 
monotherapy [47]. 
2.3 Neuro-imaging of Cryptococcal Meningitis 
Data on the neuro-radiological findings of CM are scanty and limited to case reports and 
small case series. The largest reported series is by Charlier et al and comprised 62 cases of 
whom 24 had magnetic resonance imaging (MRI) scans and 38 had computerized 
tomography (CT) scans [48]. Ninety-two percent of MRI scans performed were abnormal 
compared to 53% of CT scans. MRI was also more sensitive than CT in detecting 
abnormalities (78 % vs. 24%) in 17 patients who had both modalities. In the multivariate 
analysis, patients with high serum cryptococcal antigen titres and neurological abnormalities 
were more likely to have cryptococcal related lesions on imaging. The neuro-radiological 
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lesions related to CM included: dilated perivascular space, pseudocysts, cryptococcoma, 
basal meningitis and hydrocephalus. Hydrocephalus is an infrequent finding possibly due to 
equivalent pressure over the surface of the brain and within the ventricles. When 
hydrocephalus is present it is usually very mild. The frequency and type of radiological 
lesions from CM have not been documented in South Africa. Paper 3 in Chapter 5 will 
endeavor to address this and correlate clinical features with radiological abnormalities 
detected. Table 1 from Charlier et al [48] and Figure 1 show the published series from 1982-
2009 of the frequencies of radiological abnormalities in HIV associated cerebral 
cryptococcosis. MRI is more sensitive in detecting dilated Virchow Robin Spaces (VRS) and 
meningitis. 
Table 1: Reported series of radiological findings in HIV associated cerebral 




Figure 1: Pie graph of meta-analysis in Table 1 demonstrating relative frequency of CT and MRI 









2.4 Visual loss in Cryptococcal meningitis 
Complications of CM include visual loss, deafness, cranial nerve palsies, dissemination to 
other organs and death from raised intracranial pressure [38]. Visual loss is common and 
reported to occur in 30-45% of cases. Rex et al first classified visual loss as occurring either 
early or late in the illness [10]. Early visual loss was reported as due to optic nerve 
infiltration/inflammation and occurred within 6 days of the onset of meningitis symptoms, 
whereas late visual loss occurred a few weeks into the infection and was due to optic disc 
oedema from raised intracranial pressure (papilloedema). The rapid visual loss group had 
elevated CSF pressure in over 90 % of patients, thickened optic nerves on CT scan in 22% 
and symmetrical visual loss in 93%. The visual loss occurred before or soon after initiation of 
antifungal therapy and was severe and permanent. The slow visual loss group did not differ 
much, having elevated CSF pressure in 83%, thickened optic nerves in 22% and symmetrical 
visual loss in 93%. As to whether there was dilatation of the peri-optic CSF space or 
thickening of the optic nerve itself was not defined on CT scan for both groups. Therefore, 
apart from the tempo of presentation, a clear distinction between these groups does seem 
artificial.  We too have previously shown that raised intracranial pressure is common in CM 
induced visual loss (69%) but that papilloedema was present in only 25% [49]. 
 Various reports have supported or refuted these claims with evidence for and against the 
optic neuritis and papilloedema model [11-18]. Recovery however has always been 
documented as poor. Medical treatment alone is insufficient as demonstrated by Graybill et al 
were steroids alone were ineffective but serial LP’s and reduction of CSF pressure were more 
successful [5]. In Torres’s meta-analysis of rapid and slow visual loss cases the outcome was 
generally poor when only the underlying CM was treated and not the visual loss [50]. 
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Attention to the pathogenesis of visual loss in CM is paramount in survivors due to the 
profound disability that follows.  
By comparing the diffusion imaging findings in CM to those in patients with established and 
unrelated causes of papilloedema and optic neuritis, we will attempt to establish the 
pathogenesis of cryptcoccal induced visual loss. 
 
2.4.1 The Papilloedema Model 
Raised intracranial pressure in CM is well documented. CSF outflow obstruction by plugging 
of the arachnoid granulations with the organism or polysaccharide capsule is postulated to 
result in the elevated intracranial pressure [51]. Good support for obstruction at the arachnoid 
villi has come from Loyse et al who have shown histopathologically that fungal loading does 
occur at the arachnoid villi and is positively correlated with elevated intracranial pressure 
[19]. Bicanic et al have shown that higher fungal burden and higher cryptococcal antigen titre 
is associated with higher intracranial pressure and have therefore recommended early and 
aggressive fungicidal treatment with lowering of intracranial pressure by either serial lumbar 
puncture or  lumbar drainage to lower morbidity and mortality in patients with CM [52]. 
Garrity et al in 1993 performed optic nerve sheath fenestrations in 2 patients with visual loss 
and papilloedema [53]. Both patients had improved vision following the procedure in 
conjunction with lowering of intracranial pressure. Cryptococcal organisms were present in 
the dural sheaths of both patients. At autopsy of one of the patients, patency of the sheath 
fenestration was still present. 
The evidence for visual loss resulting from raised intracranial pressure and papilloedema and 
the benefit from CSF pressure lowering either by serial lumbar punctures [5, 14, 16, 51, 54], 
12 
 
acetazolamide [54, 55], lumbo-peritoneal (LP) shunt, lumbar drain [15, 17, 56], ventriculo-
peritoneal  (VP) shunt [51, 57] and optic nerve sheath fenestration [18, 53] are many, but 
mostly anecdotal. Medical approaches to control of raised intracranial pressure in CM have 
not been shown to be effective. The risks of lumbar drains, VP and LP shunts are over 
drainage, shunt infection, distal catheter migration and need for shunt revision [58].  VP 
shunts are associated with lower risk of shunt obstruction and revision than LP shunts. 
 CT or MRI scans show normal ventricular size in most cases of CM despite elevated CSF 
pressure possibly due to equivalent pressure between the intraventricular fluid and the CSF 
surrounding the brain [51]. No doubt raised intracranial pressure and fungal loading are 
common and well described in CM sufferers, but inflammation is minimal if any in HIV 
infection. The significance of raised intracranial pressure cannot be underestimated in visual 
loss and perhaps optic disc swelling and optic nerve infiltration/inflammation are secondary 
or co-occurrences. Reports of raised intracranial pressure related visual loss are many in the 
literature and the  benefit of early lowering of intracranial pressure in reversing blindness in 
cryptococcal induced visual loss is well documented [14, 15, 57, 59]. 
The effect of papilloedema on DWI and DTI parameters of the optic nerve is unknown. We 
will endeavor to establish such parameters and compare them to those of normal healthy 
volunteers. 
2.4.2 The Optic Neuritis Model  
Evidence for optic nerve infiltration by Cryptococcus neoformans has come from case reports 
only. Lipson et al first described 2 cases of AIDS associated cryptococcal arachnoiditis 
resulting in bilateral visual loss secondary to an optic neuropathy [13]. Ofner ‘s claim of optic 
nerve infiltration in a patient with visual loss and elevated intracranial pressure was not 
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strong [60]. Histology obtained from the optic nerve sheath showed fungal infiltration with 
inflammation, but optic nerve infiltration was only presumed.  Histological evidence of 
cryptococcal infiltration of the intracanalicular segment of the optic nerve with associated 
necrosis was provided by Cohen et al in 1993 [12] and further supported by a 
histopathological case reported by Corti et al in 2010 [61]. Corti’s case also showed a 
perineuritis, but in addition showed optic nerve infiltration by the fungus. By inference, 
Hoepelman [62] and Seaton [11] have suggested that corticosteroids could only play a 
beneficial role in cryptococcal induced visual loss by reducing the optic nerve inflammation 
so induced by the organism. Further support for an optic neuritis model has come from De 
Schacht’s report of a 26 yr. old CM patient who developed an immune reconstitution illness 
with bilateral blindness after starting antiretroviral therapy [63]. Supposedly, the exaggerated 
optic nerve inflammation secondary to fungal infiltration caused the bilateral blindness. 
Unfortunately, such case reports in the literature are scanty and the evidence for optic nerve 
infiltration is largely speculative [8]. 
 
2.5 In vivo examination of Optic Nerve structure and function  
In establishing the pathogenesis of CM induced visual loss one is faced with many 
challenges. Firstly, obtaining autopsies in black patients in South Africa is extremely difficult 
as it violates the African culture to perform incisions on the human body post mortem [64]. It 
is believed that the spirit continues to reside in the human body post mortem and provides a 
protective role to future generations. It is thus avoided unless required for legal purposes. 
Secondly, the effects of raised intracranial pressure on the optic nerve are lost post mortem 
and difficult to interpret. In vivo investigations are therefore preferred to investigate the effect 
of raised pressure on the optic nerve. 
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In vivo examination of optic nerve structure and function includes visual acuity testing, visual 
field testing (Humphreys Visual Field (HVF)), Visual evoked potentials (VEP), MRI, DWI 
and DTI of the optic nerve. 
 
2.5.1 Anatomy of the optic nerve and the peri-optic space 
The optic nerve is formed from the ganglion cell axons of the retina and comprises 4 
segments (Figure 2). The 1st segment, the optic disc is 1mm long and unmyelinated. The 2nd 
segment begins at the sieve-like lamina cribrosa where myelination of the nerve begins and 
extends to the optic canal. This segment is 25 mm long and somewhat S shaped to allow for 
unrestrained movement of the globe within the orbit. The 3rd segment lies within the optic 
canal with the ophthalmic artery and is 4 mm long. The 4th segment, which is 16mm long 
lies intracranially and merges with the opposite nerve at the optic chiasm where crossover of 
the nasal fibres occur. Both temporal and crossed nasal fibres continue within the optic tract. 
Myelination of the optic nerve, unlike the other cranial nerves is by oligodendrocytes and is 
therefore considered to be a white matter tract by some rather than a cranial nerve. The nerve 
consists of approximately 1.2 million axons of which 10% are responsible for the light reflex. 
The remainder of the nerve fibres is responsible for colour vision and motion perception with 
some centripetal fibres of unknown function.   
Surrounding the optic nerve from the globe to the optic canal is the optic nerve sheath which 
consists of the dura, arachnoid and pia. CSF occupies the subarachnoid space and is 
continuous with the intracranial subarachnoid space. CSF that is produced from the choroid 
plexus and ependyma of the ventricles flows into the subarachnoid space of the basal cisterns 
and eventually into the peri-optic subarachnoid space. So presumably, the intracranial 
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pressure is transmitted via this route to the peri-optic space and ultimately to the lamina 
cribrosa. In raised intracranial pressure, the raised pressure applied at the lamina cribrosa is 
responsible for axoplasmic stasis and axonal swelling at the optic nerve head which is 
visualized as optic disc oedema (papilloedema) [7]. CSF flow within the peri-optic space 
conceivably is bidirectional towards the globe where it reaches a dead end and then back 
towards the brain [65, 66].  This process is slower than the flow intracranially due largely to 
the smaller size of the optic nerve sheath and the presence of septae, trabeculae and pillars 
within the peri-optic subarachnoid space SAS [67].  
 
Figure 2: Optic nerve anatomy and CSF pathways. Adapted from Killer H.E [66]. 
 
 
A – Intracranial SAS 
B – Peri-optic SAS 
C – Optic Canal Segment of the 
Optic nerve 
D – Orbital Segment of the Optic  
nerve 




Killer et al have demonstrated by electron microscopy the presence of a meshwork of 
trabeculae of 5 to 7 µm diameter in the bulbar segment of the nerve closest to the globe. The 
trabeculae are sometimes linked by a veil-like pattern. In the mid-orbital portion of the nerve, 
the peri-optic subarachnoid space contains “broad septae and stout pillars” of 10 -30 µm. The 
pillars have larger bases and attachments to the dura. The subarachnoid space of the 
canalicular segment is extremely narrow and has large pillars of 0.5mm diameter and smaller 
ones of 25 µm (Figures 3-6) and few trabeculae but no septae. These trabeculae, septae and 
pillars are formed by leptomeningeal cells, fibroblasts, collagenous fibrils and blood vessels.   
Killer describes the peri-optic SAS as therefore ‘not a homogeneous space filled with CSF, 
but a multichambered and subdivided tubular system with a blind end (cul de sac) behind the 
ocular globe’ [67]. Observation of unilateral and asymmetrical papilloedema as occurs in 
idiopathic intracranial hypertension further support the theory of differential pressure 
between the peri-optic SAS and intracranial SAS. CSF drainage into the surrounding optic 
nerve sheath lymphatics is minimal. For technical reasons, the pressure in the peri-optic SAS 
has not been measured. Cadaveric studies were based on hypotheses and not true 
measurement[68]. The two CSF systems are not freely connected, due to the presence of this 
meshwork of trabeculae, septae and pillars within the peri-optic SAS.   Presumably, laminar 
flow of CSF within this space occurs which is necessary to allow for CSF exchange between 
the intracranial SAS and peri-optic SAS, albeit a slow and compartmentalized process [66]. 
Seemingly, flow of CSF from the site of production to the peri-optic space is by a 
combination of bulk flow of newly produced CSF, postural effects, ventricular pulsations and 
pulse pressure of the choroid plexus.   
The role played by the peri-optic CSF space trabeculae, septae and pillars in CM is unknown. 
Histology from optic nerve sheath fenestration has shown infiltration of the optic nerve 
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sheath by the cryptococcal organism [18]. We postulate that there is plugging of the optic 
nerve SAS by the organism which is facilitated by the trabeculae, septae and pillars. The 
brunt of the blockage must occur at the optic canal level where the SAS has the smallest 
opening. The maximum intracranial pressure is therefore most likely applied at the optic 
canal level. Compression at this site is consistent with the compartment syndrome described 
by Killer et al in optic neuritis and idiopathic intracranial hypertension (IIH) [66, 69].  
 
a – bulbar segment, b – mid orbital segment, c – intra-orbital optic nerve 
Figure 3: Schematic drawing of the optic nerve demonstrating the bulbar, mid-orbital 
and canalicular segments of the optic nerve. (From Killer HE et al Architecture of 
arachnoid trabeculae, pillars, and septae in the subarachnoid space of the human optic 





Figure 4:  Electron microscopy appearance of the subarachnoid space of the bulbar segment 
showing trabeculae and a veil-like cytoplasmic extension between trabeculae. Arrows point 
to the veil-like cytoplasmic extensions. From Killer HE et al   [67] 
Electron Microscopy appearance of the 
subarachnoid space in the bulbar 
segment.  
(A) Overview of the subarachnoid space 
showing the complex network of 
trabeculae. The arrows point to veil-like 
cytoplasmic extensions between 
adjacent trabeculae (bar = 150 μm).  
(B, C) Delicate subarachnoid space 
network formed by branching 
trabeculae (bar = 50 μm). The arrow 
points to a trabeculum with a blood 
vessel. Note again the veil-like 
cytoplasmic extensions connecting 
adjacent trabeculae (bar = 2 μm).  
(D) Surface of trabeculae covered by 
flattened cells with distinct intercellular 




Figure 5: (A,B,C,D) Electron microscopy appearance of the subarachnoid space of the mid-orbital 
segment showing septae and trabeculae. N = optic nerve. Arrows point to the septae. From Killer 
HE et al  [67] 
 
 
Electron Microscopy morphology of the 
subarachnoid space in the mid-orbital 
segment. 
 (A) Overview of the subarachnoid 
spacesubdivided by well defined septa 
(arrows), N = optic nerve (bar = 150 
μm). 
 (B) Arachnoid septum within the 
subarachnoid space; note the septal 
perforations connecting adjacent 
subarachnoid space chambers (bar = 25 
μm).  
(C) Pillar bridging the subarachnoid 
space and extending into the dura layer 
of the arachnoid (bar = 30 μm). 
(D) Detail of a septum with typical 




Figure 6: (A,B,C) Electron microscopy appearance of the subarachnoid space of the canalicular 
segment showing pillars and trabeculae. N = optic nerve. Arrows point to the pillars. From Killer HE 
et al  [67] 
 
2.5.2 Clinical evaluation of Optic nerve functioning [70] 
There are 5 tests of optic nerve function. The 1st is visual acuity which is tested by using 
Snellen Charts that range from 6/60 (20/200) to 6/5 (20/15) vision. If vision is worse than 
6/60 then either the patient is brought closer to the chart and graded accordingly or vision is 
evaluated at 1m for counting fingers (CF), hand movements (HM), light perception (LP) or 
no light perception (NLP). Best corrected visual acuity is obtained with refractive lenses or a 
pinhole and documented as such. Best corrected visual acuity using Snellen charts are 
subjective and are especially difficult in encephalopathic patients. LogMar charts are equally 
difficult to perform on such patients. 
The 2nd test is the light reflex which is tested with a bright and focused light source. The 
direct light reflex is a 4 neuron pathway starting from the optic nerve to the pretectal nucleus, 
Morphology of the subarachnoid space 
in the intracanalicular segment.  
(A) Overview of the subarachnoid space; 
A = ophthalmic artery, N = optic nerve 
(bar = 15 μm) (the optic nerve is turned 
180°).  
(B) Pillars (arrows) and trabeculae 
(arrowheads) transversing the 
subarachnoid space (bar = 30 μm). 
(C) Trabeculae within the subarachnoid 
space found at the orbital opening of 
the optic canal (bar 30 μm). 
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2nd neuron to the Edinger-Westphal nucleus, 3rd neuron along the 3rd cranial nerve to the 
ciliary ganglion and finally the 4th neuron from the ciliary ganglion to the iris as the short 
ciliary nerve. Crossover at the optic chiasm and bilateral innervation of the Edinger-Westphal 
nuclei from each pretectal nucleus allows for the consensual reflex. The direct light reflex 
tests the afferent and efferent pathways of the same eye whereas the consensual light reflex 
tests the afferent pathway of the ipsilateral eye and the efferent pathway of the contralateral 
eye. Optic nerve disease results in an absolute or relative afferent pupillary defect whereas 
3rd nerve palsy causes an efferent pupillary defect. 
The 3rd test of optic nerve function is the testing of colour vision which is done using Ishihara 
pseudo-isochromatic plates. Colour vision is scored according to the number the patient 
reports correctly. Colour desaturation is tested by asking the patient to comment on the colour 
of the red top of the Mydriacyl bottle and comparing between eyes for patients with unilateral 
disease. Colour desaturation is an early and common abnormality in optic neuritis. 
The 4th test is visual field testing which at the bedside is done by confrontation. Each eye is 
tested separately. The central field is tested by asking the patient to comment on the 
examiners face while the patient fixates on his nose. This detects central scotomas of optic 
nerve and macular dysfunction. The patient is then asked to count the examiners fingers in 
the different quadrants. And finally hand comparison is done between the hemispheres to 
detect subtle field loss. 
The 5th test of optic nerve testing is funduscopy. The optic disc is viewed by direct or indirect 
ophthalmoscopy. Its colour, shape, size, optic cup size, neuro-retinal rim, disc margins, and 
spontaneous venous pulsations are described. 
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Contrast sensitivity is becoming the gold standard for assessing optic neuritis in multiple 
sclerosis but is less often used for other optic neuropathies [71].  
For complete assessment of optic nerve structure and function, such tests are required.  
2.5.3 Electrophysiological testing of optic nerve function 
2.5.3.1 Visual Evoked Potential (VEP) [72] 
VEP testing has the advantage of objectivity. Pattern reversal VEP uses a checker board 
pattern and is used in co-operative subjects who can fixate on a target. The subject is seated 1 
metre away from the monitor that flashes the checker board pattern. In pattern reversal, the 
black squares become white and vice versa after every second. Each eye is tested separately. 
Active and reference electrodes placed over the occiput detect the evoked potential difference 
obtained from the occipital lobe. One hundred averages of the evoked response is obtained 
which produces a triphasic wave of initial negativity after approximately 80 milliseconds 
(ms) (N80), secondly a following positive wave after 100 ms (P100) and thirdly a negative 
wave after 145 ms (N145). Flash VEP requires less co-operation and can be done with 
goggles especially in patients with poor visual acuity. Comparisons are made with reference 
laboratory ranges. The most reproducible waveform is the P100 wave which is preceded by 
the N80 wave and followed by the N145 wave. The amplitude and latency of the P100 
waveform provides information about the number of functioning axons and the amount of 
demyelination of the optic nerve respectively. Optic nerve inflammation as occurs in optic 
neuritis is well documented on VEP. The latency prolongation is an early abnormality of 
optic nerve inflammation and demyelination. Amplitude reduction of the P100 waveform is 
secondary to axonal loss and is usually an event that follows an acute or subacute insult. 
Reduced amplitude occurs less frequently from conduction block. The P100 latency is 
23 
 
measured from the stimulus onset of pattern reversal to the onset of the P100 waveform. 
Amplitude is measured from the negative peak of the N80 waveform to the positive peak of 
the P100 waveform. Our laboratory references for these parameters are 104 (±10) ms for 
VEP P100 latency and 15 (±5) µV for the N80 – P100 amplitude. The effect of raised 
intracranial pressure on VEP has been studied in Idiopathic Intracranial Hypertension, but not 
in neuro-infectious disorders. 
The advantage of Flash light-emitting diode (LED) goggles is that minimal co-operation is 
necessary and can be performed on patients with poor visual acuity. However, there is 
suboptimal reproducibility and marked variability. The P100 waveform latency obtained with 
Flash LED goggles ranges from 76.1 – 162.5 ms in our laboratory and the normal N80-P100 
amplitude ranges from 9.3 – 22.5µV. Quantitative analysis of Flash LED VEP is therefore 
unreliable. The presence of a waveform is indicative of optic nerve functioning, but the 
degree of functioning cannot be reliably quantified. 
2.5.3.2 Humphrey Visual Field 
The automated Humphrey visual field (HVF) provides reliable and early field defects in 
asymptomatic patients and is therefore a useful tool in detecting subtle visual disturbances in 
asymptomatic subjects. Automated HVF are usually performed using the 30–2 Swedish 
interactive threshold algorithm (SITA) standard protocol. HVF 30-2 are more readily 
available and produce a larger field than the 24-2. Pattern deviation fields that fulfill 
acceptable reliability indices are included for analysis. Acceptable reliability indices of HVF 
are fixation losses of 33%, false negatives of 33% and false positives of 33%. Good co-
operation is required for HVF testing so encephalopathic patients are poor candidates. The 
HVF has not been used to evaluate visual loss in CM, but has been studied in HIV infection. 
Non-specific superior and inferior field defects have been reported by Sample et al,  at all 
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stages of HIV infection unrelated to infectious retinopathy and they have postulated optic 
nerve pathology [73]. From 151 eyes of 81 HIV positive patients, 88 had normal visual fields, 
11 had field loss by mean defect only, 32 had early field loss and 20 had moderate field loss.   
Visual field defects are useful in localizing visual pathway pathology. Optic nerve pathology 
is associated with central scotoma, centrocecal scotoma, arcuate defects, altitudinal defects, 
hemi-anopic defects and junctional scotoma [74]. In the optic neuritis treatment trial (ONTT) 
visual field defects in the affected eye at presentation included diffuse visual field loss (48%), 
altitudinal defects (15%), central or centrocecal scotoma (8.3%), arcuate or double arcuate 
(4.5%), hemianopic defects (4.2%), and others [75, 76].  Papilloedema is associated with 
large blind spots, constricted peripheral field and early inferonasal deficits [74]. Other less 
common field defects described include inferior altitudinal loss, superonasal and 
superotemporal loss, arcuate defects, and scotomas (central, centrocecal, and paracentral). 
Goldmann kinetic fields are more sensitive in detecting peripheral visual field loss but are not 
universally available. 
 
2.6 Imaging of the optic nerve 
MRI of the optic nerve is technically challenging due to its small size, the effect of 
surrounding CSF and orbital fat and the presence of nearby bone structures (Figure 7) [33, 
77, 78]. In DWI, the image is sensitized to the microscopic motion of water molecules within 
the nerve, so the macroscopic motion of the nerve within the orbit poses extra problems [22, 
79].  
Most advances in optic nerve imaging have come from work done in optic neuritis [80]. 
Conventional imaging of the optic nerve on MRI includes T1 axial, coronal and sagittal, T2 
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axial and coronal and T2 fluid attenuated inversion recovery (FLAIR) followed by post 
contrast images with gadolinium on T1 images. Orbital fat suppression has been an important 
addition in the last 10 years for better identification of the optic nerve on T1 and T2 imaging. 
Initially short tau inversion recovery (STIR) was used for fat suppression, but was followed 
by selective partial inversion recovery (SPIR) which has become the more favoured 
technique. SPIR when combined with FLAIR provides the added advantage of CSF 
suppression. CSF suppression also allows for better identification of the nerve on axial and 
coronal imaging but most importantly prevents volume averaging of the surrounding CSF 
during optic nerve diffusion analysis. Currently, modification of the standard spin echo 
imaging of the optic nerve within the orbit includes T1 3D fat saturated (SPIR) axial, T2 3D 
turbo spin echo (TSE) coronal, T2 3D high resolution axial TSE, T1 3D SPIR axial post 
contrast. Various combinations of fat saturation and fluid attenuation are employed to 
minimize artifact. 
Further developments in optic nerve imaging have included Magnetic Transfer Ratio (MTR) 
of the entire nerve giving an indication of the degree of demyelination and re-myelination 
over the entire lesion in optic neuritis. With DTI and DT tractography, it is now possible to 
trace the entire visual pathway from the optic nerve to the striate cortex [81]. Most 
significantly, improved DWI and DTI quantitative measurements have provided considerable 






Figure 7. MR related features of the optic nerve (From Barker GJ et al, DWI of the 




Molecular diffusion, or Brownian diffusion was first described mathematically by Einstein in 
1905 [82]. Diffusion of water molecules in a glass of water is unrestricted and occurs 
randomly and in a defined period of time, the net diffusion is 0 due to its Gaussian 
distribution. Such diffusion is described as isotropic and is equal in all directions. The volume 
of diffusion is represented by a sphere. Diffusion of water molecules in neuronal tissue 
however is restricted due to the tightly packed axons and glial cells that are organized in 
bundles. Greater diffusion of water molecules occur in the direction of the axons as opposed 
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to perpendicular to it. Such diffusion is referred to as anisotropic and is represented by an 
ellipsoid [83].  
 
2.6.2 Diffusion Weighted Imaging 
The Brownian motion of water molecules has been imaged on MRI scans since the 1980’s 
and is referred to as DWI. The technique can characterize the water diffusion properties of 
each pixel of an image. Both qualitative and quantitative data are obtainable from DWI.  
The technique is based on detecting signal loss after placing pulsed dephasing and rephasing 
gradients within the magnetic field during image acquisition.  
When there is no gradient, protons (hydrogen atoms within the water molecule) precess at a 
similar rate and are in phase within the main magnet (Figure 8). When the 1st gradient is 
applied, depending on their location, protons precess at different speeds and dephasing 
occurs. After application of the 2nd gradient of opposite magnitude, rephasing of the protons 
occurs and the original signal is recovered if the same number of protons return the signal. If 
however there has been movement of the protons during application of these 2 pulse 
gradients, the signal recovered will be less and signal loss will occur.  The greater the signal 







Figure 8. Gradient diagram and signal phases under application of a gradient. From 
Mori S et al  Diffusion magnetic resonance imaging: its principles and applications [27]. 
 
The length of grey arrows indicate schematically the relative strength of the magnetic field 
2.6.2.1 Signal strength, ADC and b value 
The amount of signal loss is described by the Stejskal Tanner equation; 
        [1] 
 
Where: S – Signal intensity with gradient application, S0 – Signal intensity without gradient 
application, γ – Gyromagnetic ratio (nuclear constant), G – Strength of gradient pulse, δ  - 
Duration of gradient pulse, Δ - Time between the 2 gradient impulses, D – Diffusion 
coefficient or constant 
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From the Stejskal Tanner equation 1 it is evident that the higher the diffusion constant D, the 
greater the strength of the gradient (G) and the longer it is applied (δ) and the greater the 
interval between the gradients (Δ), the greater the signal loss. 
The ‘b’ value of a gradient is a useful indication of the strength and duration of the pulse 
gradient applied and is defined as follows; 
         [2] 
 – Gyromagnetic ratio (nuclear constant), G – Strength of gradient pulse, δ- Duration of 
gradient pulse, Δ - Time between the 2 gradient impulses 
From equation 2 it is evident that the larger the ‘b’ value, the greater the diffusion weighting. 
When the value of ‘b’ is 0, the image is equivalent to a T2 weighted image. With higher 
values, there is greater strength of the gradient and more time for water diffusion. Table 2 
shows the ‘b’ values used in the different methods of optic nerve diffusion. 
Table 2.  The ‘b’ values used in DWI by the listed investigators 
Study b value 
s/mm2 
Iwasawa et al [32] 262.05 
Wheeler-Kingshott et al [33] 600 
Chabert et al [34] 500 




The amount of signal loss from b0 to a higher ‘b’ value is expressed as a slope. The gradient 
of this slope is the Diffusion Coefficient and can be obtained for each pixel in the image 
(Figure 7). A map of these calculated Diffusion Coefficients creates the ADC image. 
 







Figure 9 shows the relationship between signal loss and the gradient applied. When the 
diffusion is greater, the signal loss is more and the slope is steeper resulting in a larger ADC. 
Therefore a large ADC is indicative of greater diffusion [27]. 
2.6.3 Diffusion Tensor Imaging 
MRI can measure diffusion in any direction using the 3 main axes of X,Y and Z. In the case 
of an isotropic medium, the ADC measured does not depend on the direction of 
measurement. There is unrestricted diffusion in the shape of a sphere (Figure 10a). In 
neuronal tissue however diffusion is ellipsoidal due to the restriction offered by the axons and 
glial tissue, where greater diffusion occurs along the axons than perpendicular to them. The 









and λ3 (where λ1, λ2 and λ3 are the principal axes in an ellipsoid) (Figure 10b).  When 
calculated in the direction of imaging this is easy to compute, however if the ellipsoid is 
oblique to the direction of imaging, then a 3 x 3 Diffusion Tensor is required to calculate the 
Diffusion constants where each entry is not a zero value (Figure 10c). While DWI is used to 
assess diffusion in 3 orthogonal axes, DTI can solve the complete diffusion tensor, but 
requires diffusion to be applied in a minimum of 6 directions. 
The mathematical properties of the Diffusion Tensor make it possible to extract a number of 
useful parameters in assessing diffusion. DTI provides the MD which is a scalar average of 
the sum of the 3 eigenvectors λ1, λ2 and λ3. 
MD = 1/3(λ1 + λ2 + λ3).         [3] 
FA is a scalar value that describes the shape of diffusion. It ranges from 0 to 1 where 0 
represents isotropic diffusion as occurs resulting in the shape of a sphere and 1 (never 
happens in life) represents anisotropic diffusion as occurs in the limit of an ellipsoid which is 
a straight line. FA is computed by comparing each eigenvalue (λ1, λ2 and λ3) to the mean of all 
eigenvalues and is calculated by using equation 4. 







Figure 10. Relationship between anisotropic diffusion (upper row), diffusion ellipsoids 
(middle row), and diffusion tensor (bottom row). (From Mori S et al [27] ) 
 
 
2.6.4 Anisotropic Parameters 
Diffusion in an anisotropic medium is described as occurring in an ellipsoidal shape as occurs 
in the white matter of the brain and in the optic nerve. The ellipsoid has a long axis that 
describes its length and 2 smaller axes that describe its depth and width. These 3 axes are 
perpendicular to each other and cross at the midpoint of the ellipsoid. The diffusion vector 
components along the axes are referred to as eigenvectors and their lengths as eigenvalues. 
Diffusion is fast along the length of an axon and slow perpendicular to (or across) it. The 
diffusivity that occurs along the axon (λ1) is referred to as the longitudinal, axial or parallel 
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diffusivity and the other 2 minor axes (λ2, λ3,) are referred to as the radial diffusivity or 
perpendicular diffusivity.  
 
2.6.4.1 Axis ratio 
The simplest index of anisotropy is the axis ratio i.e. the ratio between the long axis to the 
short axis of the ellipsoid (λ1/ λ2) on DTI or ADCZ/ADCY on DWI. However this is 
susceptible to measurement noise so other measures have been adopted. 
2.6.4.2 Anisotropic Index (AI) 
The AI [33] refers to the ratio of the axial diffusivity to the radial diffusivity. 
On DWI:  AI = ADCZ/ADCXY        [5] 
 Where ADCZ represents the axial diffusivity and ADCXY is the average of the radial 
diffusion axes i.e.  
ADCXY = (ADCX + ADCY)/2 
On DTI:  AI = λ///λ⊥ = 2λ1/(λ2 + λ3)       [6] 
The radial diffusivities are often averaged as λ⊥ = (λ2 + λ3)/2, where λ⊥ represents the radial 
diffusivity. λ// represents the axial diffusivity.    






2.6.4.3 Fractional Anisotropy (FA) 
To minimize measurement noise, the FA was introduced (Equation 4). An FA map is 
determined by solving the diffusion tensor. FA is computed from the eigenvalues of the 
tensor. FA values are obtained from the signal intensity on the FA maps. FA is therefore an 
objective and reproducible measure of anisotropy. 
2.6.4.4 Relative Anisotropy (RA) 
RA represents the ratio of the anisotropic part of diffusion to its isotropic part [84]. RA varies 
between 0 (isotropic diffusion) and √2 (infinite anisotropy), but is used less often than FA. 
 RA   =                                           [7] 
2.6.4.5 Volume Ratio (VR) 
The VR represents the ratio of the ellipsoid volume to the volume of a sphere of radius (λ). 
Its range is from 1 (isotropic diffusion) to 0 (anisotropic diffusion), therefore some authors 
prefer to represent it as (1-VR) [84].  
 VR =                      [8] 
2.6.4.6 Other Scalar Anisotropic Indices 
There are other scalar anisotropic indices that are infrequently used. They are less preferred 
as they are not really quantitative and are dependent on the choice of directions made for their 
measurements [84]. They include; 
1. max[ADCx, ADCy, ADCz]/ min[ADCx, ADCy, ADCz] 
2. σ[ADCx]/ meanADCx or σ[ADCy]/ meanADCy or σ[ADCy]/ meanADCy 
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2.6.5 Optic nerve diffusion imaging 
Optic nerve diffusion imaging on DWI and DTI can be used to demonstrate the anisotropic 
diffusion of water molecules within the optic nerve. Disruption of this process occurs in optic 
nerve pathology.  
Optic nerve diffusion has gained prominence as a useful investigational tool of optic nerve 
microstructure and pathology [22, 81, 85]. While initially employed to reveal the chronic 
effects of optic neuritis on optic nerve structure, its usage in recent studies has also shown 
early changes in acute optic neuritis [79]. The benefit of detecting these early changes would 
be to offer better understanding of the pathophysiology of processes impacting the optic 
nerve and hopefully provide direction to devise better strategies to prevent and reverse such 
damage.  Optic nerve diffusion has been determined for other optic nerve disorders viz. 
ischaemic optic neuropathy, glaucoma and cryptococcal induced visual loss [24, 49, 86]. The 
diversity of disorders investigated has resulted in a variety of different pulse sequences and 
imaging protocols being used when performing diffusion studies on the optic nerve and good 
consistency of diffusion parameters has been shown for all these methods. Such diffusion 
techniques include Iwasawa’s Intravoxel incoherent motion (IVIM) [32], Wheeler-
Kingshott’s zonal oblique multislice echo planar imaging (ZOOM EPI) [33], Chabert’s  non-
Carr-Purcell-Meiboom-Gill fast spin echo ( non CPMG FSE) [34] and our coronal oblique 
method [49]. All methods unfortunately have their own limitations. The optic nerve is 
surrounded first by CSF within the optic nerve sheath, then by fat within a bony orbit which 
is bordered by paranasal sinuses containing air. In most of the optic nerve diffusion 
techniques, FLAIR and fat saturation are utilized to overcome the CSF and fat artifact 
surrounding the nerve. In addition to fat saturation to overcome the fat signal, we have used a 
high diffusion gradient of B1000 instead of FLAIR to overcome CSF artifact [49].  The 
36 
 
benefit of this was the improved identification of the hypo-intense optic nerve on B0 images 
surrounded by the hyper -intense CSF in the peri-optic space.   Susceptibility artifact from the 
bone and air are overcome by using sensitivity encoding (SENSE), averaging and Rayleigh 
noise reduction [33]. Optic nerve motion however cannot be eradicated, but merely reduced 
by asking the subject to relax listen to relaxing music, and focus on a target placed in their 
central field of view. We have asked subjects to focus on an orange sticker placed overhead 
on the MRI machine. Despite this, eye movement (voluntary or involuntary) continues and it 
is not uncommon with single shot echo planar imaging (EPI) to image an apparent ‘double 
nerve’ due to movement. The impact of this movement on optic nerve diffusion parameters 
and the impact of movement on diffusion of the surrounding CSF have not been previously 
investigated. 
2.6.5.1 CSF suppressed ZOOM-EPI technique of Wheeler-Kingshott [33] 
The ZOOM –EPI technique is done on both optic nerves coronally and simultaneously using 
a 1.5T General Electric MR scanner. Oblique imaging at 73° avoids wraparound artifact 
where a double image is obtained due to a small field of view (Figure 11).  Single shot EPI 
was used for rapid imaging to reduce motion artifact however EPI is still prone to 
susceptibility artifacts. CSF and fat were also suppressed to reduce the artifact induced by the 
overlying CSF and orbital fat. Diffusion sensitizing gradients were applied in 3 directions 
using a ‘b’ gradient value of 600s/mm2 with a repetition time of 3.6s and averaging of 40 
acquisitions. Twelve 4mm slices were collected in 28min 12s. Matrix and field of view 
(FOV) were 64 x 32 and 8 x 4 respectively. Repetition time (TR) was 3400ms and echo time 
(TE) was 100ms. The mean ADC was calculated from the 3 orthogonal planes as (ADCx + 
ADCy + ADCz)/3 and over the whole nerve was 1.058mm2/s ± 0.101 x 10-3 (range 0.83 – 1.18 
x 10-3mm2/s) (Table 3). The ADCz obtained in the orthogonal plane was greater than the 
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ADC obtained in plane to the imaging plane suggesting anisotropic diffusion. The anisotropic 
index was thus derived from ADCz/ADCxy where ADCxy was (ADCx + ADCy)/2. The average 
of this index was 1.57 with standard deviation (SD) of 0.34 and range (1.16 – 2.4) (Table 3). 
The head was positioned in a quadrature birdcage head coil and was used as both transmitter 
and receiver. The head was positioned with foam padding on either side and the subject was 
asked to close their eyes and relax during the scan, to minimize motion artifact. 
 






2.6.5.2 Intravoxel Incoherent Motion (IVIM) technique of Iwasawa [32] 
Iwasawa et al first studied DWI of the optic nerve and presented imaging parameters they 
termed the IVIM technique. In their study, DWI was obtained in normal volunteers and 
compared to that of patients with acute and chronic optic neuritis using a 1.5T GE MR 
scanner [32].  
The IVIM method used cardiac gating and both nerves were imaged simultaneously. The 
coronal image of the optic nerves was set at 3mm anterior to the Annulus of Zinn (Figure 12). 
T2 coronal weighted imaging was used before and after application of the diffusion gradient 
to identify the nerve location. Imaging parameters used were TR of 794 – 1072 ms, TE of 
100ms, FOV of 16cm and slice thickness of 3mm with 128 encoding steps and 2 acquisitions. 
The gradient ‘b’ factor used was 262.05 s/mm2 and was calculated using the Stejskal-Tanner 
equation [88]. Diffusion was obtained in the X, Y and Z directions. Motion artifact marred 
most of their results. Mean ADC values were therefore obtained in the Y and Z directions 
only for their control group. The mean ADC in the Y direction was 0.982 ± 0.741 x 10-
3mm2/s and in the Z direction was 1.559mm2/s ± 0.675 x 10-3 (Table 3).  
The subject’s head was placed in a quadrature head coil with adhesive tape and sponge 
packing. The eyelids were also taped to attempt to limit eye movements and improve signal 
to noise ratio. Limitations of their method include the lack of fat suppression and the use of a 







Figure 12. Iwasawa’s method of Optic nerve diffusion (a) T1 weighted axial image of the 
orbit. The white line shows the coronal plane used to obtain DWI. (b) The relationship 
between the optic nerve and the directions of the 3 diffusion sensitizing gradients. The 
static magnetic field is in the X direction.[32] 
 
 
2.6.5.3 The Non-CPMG FSE technique of Chabert  [34] 
To overcome the susceptibility artifacts of EPI Chabert used the non-CPMG FSE sequence to 
acquire MR images. Iwasawa and Wheeler-Kingshott acquired diffusion images in 3 planes 
only to minimize acquisition time; however a minimum of 6 diffusion directions is required 
to define the diffusion tensor. So Chabert opted for DTI instead. 
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Images were acquired on a 1.5T General Electric MR scanner. A standard 7.6cm coil was 
positioned over the subject’s left eye to receive the signal. Diffusion gradients were applied 
along 6 directions using a gradient with ‘b’ factor of 500s/mm2. 6 repetitions were used and 
imaging time was 5 minutes for 5 slices. The FOV was 24 x 12 cm giving an in plane 
resolution of 0.94 x 0.94 mm. The FSE sequence used was single shot and 256 echoes read 
with an acquisition bandwidth of   125kHz. TE was 81ms and slice thickness was 3mm.  
Care was taken in the positioning of the subject’s head to ensure that the entire nerve was in 
the axial plane during imaging. No additional measures were taken to limit head or eye 
movement during scanning. 
MD and FA were obtained for the optic nerve on axial rather than coronal imaging (Figure 
13). Despite the lack of CSF and fat suppression in this technique of Chabert et al, the results 
are comparable to those of Iwasawa and Wheeler-Kingshott. The mean MD of the optic nerve 
was 1.1 ± 0.2 x 10-3mm2/s and FA of the nerve was 0.49 ± 0.06 (Table 3). 
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Yes No Yes Yes No Yes Yes 
CSF 
Suppression 
Yes No Yes Yes No No Yes 
ADC optic 
nerve : Mean 
(SD) x 10-3 
mm2/s 
1.058 ± (0.1) 0.98 ± (0.74)Y 
1.56 ± (0.68)Z 
     
MD optic nerve  
: Mean (SD) x 
10-3 mm2/s 
  1.22 ± (0.2) 1.08 ± (0.17) 1.1 ± (0.2) 1.09 ± (0.2) 1.25 ± (0.14) 
FA optic nerve: 
Mean (SD) 
  0.61 ± (0.1) 0.67 ± (0.09) 0.49 ± (0.06) 0.46 ± (0.15) 0.38 ± (0.05) 
AI optic nerve  : 
Median (IQR) 
1.57 (1.16-2.4)       
 
SD – Standard Deviation, % - percentage, ADC – Apparent Diffusion Coefficient measured 
using Diffusion Weighted Imaging, MD – Mean Diffusivity measured using Diffusion Tensor 
Imaging, FA – Fractional Anisotropy, AI – Anisotropic Index calculated as 2λ1/(λ2 + λ3), 
where λ1 = axial diffusion and λ2, λ3 = radial diffusion. IQR – interquartile range.  * Iwasawa 
et al obtained ADC in the Y and Z axes. ZOOM EPI – Zonal oblique multislice echo-planar 
imaging, IVIM – Intravoxel incoherent motion, Non-CPMG FSE – Non Carr-Purcell-






2.7 Optic Neuritis 
2.7.1 Pathophysiology of Optic Neuritis 
Typical optic neuritis as described in multiple sclerosis presents with acute unilateral visual 
loss, pain on eye movements, decreased contrast sensitivity and colour desaturation. Visual 
loss is usually not complete and on pupillary testing, a relative afferent pupillary defect is 
detected. Infrequently, patients have Uhthoff’s phenomenon, where deterioration of vision 
occurs when body temperature is elevated and the Pulfrich phenomenon where the 
asymmetrical slowing of electrical impulses between the eyes cause motion distortion. The 
inflammation is mostly retrobulbar (65%) and papillitis with optic disc swelling is uncommon 
[89]. MRI shows nerve enhancement in 94% of cases [90]. Histopathologically, there is 
perivascular mononuclear inflammation (cuffing), oedema in the myelinated nerve sheaths, 
and myelin breakdown. Early during inflammation, myelin loss exceeds axonal loss. 
Inflammation is immune mediated, but the specific target antigen is unknown. T-cell 
activation results in release of cytokines and other inflammatory agents. B-cell activation is 
against myelin basic protein and detection of oligoclonal bands in the CSF is evidence of this. 
The chronic sequela of optic neuritis is further loss of axons and optic atrophy. Visual 
recovery however is good with significant visual return within 2 to 3 months. 
Acute disseminated encephalomyelitis (ADEM) presents as a post viral or post vaccination 
immune mediated inflammation of the central nervous system [91]. Optic neuritis is usually 
bilateral and recovery is variable depending on the severity of inflammation. The hallmark of 
inflammation in ADEM is the perivenular inflammation by lymphocytes and macrophages. 
The margins of inflammation are indistinct and when aggressive inflammation occurs, 
haemorrhagic necrosis is an accompaniment.  
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Optic neuritis in neuromyelitis optica tends to be bilateral, recurrent and visual loss tends to 
be more severe and less reversible [92, 93]. It is an antibody mediated disease to the 
aquaporin- 4 water channel. Pathology includes immunoglobulin and complement deposition 
on the astrocytic processes of the perivascular and superficial glia limitans. There is in 
addition granulocytic, T-cells and activated macrophage/microglial cell infiltrates with 
aquaporin -4 and astrocyte loss. 
VEP in optic neuritis shows prolonged P-100 latency due to the demyelination and slowing of 
electrical impulses. P-100 amplitude reduction is minimal in acute optic neuritis and is due to 
conduction block. In chronic optic neuritis, axonal loss is prominent so the N-80/P100 
amplitude is decreased.  
 
2.7.2 Optic nerve diffusion imaging in Optic Neuritis 
The application of optic nerve diffusion in optic neuritis constitutes the majority of early 
work done in optic nerve diffusion.  
Iwasawa et al (1997) were the first to apply DWI of the optic nerves in optic neuritis in 9 
patients [32]. They utilized the IVIM technique and obtained baseline quantitative 
parameters. In acute optic neuritis, the mean ADC of the optic nerve was 0.843 ± 0.742 x 10-
3mm2/s in the Y direction (n = 3) and 0.941 ± 0.431 x 10-3mm2/s in the Z direction. There was 
no significant difference between the acute optic neuritis group and the normal volunteers. 
However there were significant differences between the optic nerve ADC in the chronic optic 
neuritis group and the normal volunteers (p < 0.001) as well as the acute optic neuritis group 
(p < 0.001) in the Z direction only. The mean ADC of the nerves with chronic optic neuritis 
was 1.56 ± 0.69 x 10-3 mm2/s in the Y direction (n = 5) and 4.18 ± 1.13 x 10-3 mm2/s in the Z 
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direction (n = 10). The authors postulate that the loss of the myelin sheath after axonal loss in 
chronic optic neuritis and the increase of extra-axonal spaces increases the ADC; presumably 
due to the higher water content. Acute plaques are different from chronic plaques. They are 
hypercellular due to the macrophage/astrocytic response and a variable degree of 
lymphocytic infiltration. One can postulate that such inflammation would decrease the ADC. 
Hickman et al (2005) using the ZOOM-EPI technique have shown similar results to Iwasawa 
in the imaging of optic neuritis 12 months after the event in 18 patients [21]. ‘The mean ADC 
from diseased optic nerves was 1.324 (standard deviation (SD) 0.379) x 10-3 mm2/s, 
compared with 0.990 (SD 0.159) x 10-3 mm2/s from healthy contralateral optic nerves (P = 
.005 versus diseased optic nerves) and 0.928 (SD 0.196) 10-3 mm2/s from control optic nerves 
(P = .006 versus diseased optic nerves and P = 0 .40 versus healthy contralateral optic 
nerves’. They too have postulated axonal disruption as cause for the elevated ADC in 
diseased optic nerves in the chronic setting. 
Trip et al using DTI and the ZOOM EPI technique of Wheeler-Kingshott obtained MD and 
FA values of the optic nerve in 25 patients with optic neuritis acquired in the previous 12 
months [22]. The mean MD from affected nerves by optic neuritis was elevated at 1.611 (SD 
290) x 10-3 mm2/s compared with 1.191 (SD 198) x 10-3 mm2/s from unaffected contralateral 
nerves (p < 0.001) and 1.083 (SD 168) x 10-3 mm2/s from control nerves (p < 0.001). ‘Mean 
FA from affected nerves was lower at 0.435 (SD 0.100), compared with 0.602 (SD 0.100) 
from clinically unaffected contralateral nerves (P < 0.001) and 0.669 (SD 0.093) from control 
nerves (P < 0.001).’ They reaffirmed the theory of axonal disruption as resulting in raised 
MD and decreased FA, but did not discount the contribution by demyelination and gliosis. 
Furthermore, they were able to show that the mean orthogonal eigenvalue perpendicular to 
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the nerve was raised compared to clinically unaffected and control nerves. Perhaps increase 
in the spaces between the axons from axonal loss permitted more orthogonal diffusion. 
Naismith et al corroborated Trips’s findings in 60 patients with a remote history of optic 
neuritis using DTI [20]. They were also able to demonstrate that radial diffusivity (orthogonal 
diffusion to the optic nerve) by Spearman coefficients, were negatively correlated to visual 
acuity (-0.61), Pelli-Robson contrast sensitivity (-0.60), VEP amplitude (-0.46) and positively 
correlated to VEP latency (0.61). 
Fatima et al were able to show a significant difference in ADC between acute (15 nerves) and 
chronic (7 nerves) optic neuritis [79]. The ADC value in acute optic neuritis was 0.9 ± 0.2 x 
10-3 mm2/s vs. 1.62 ± 0.35 x 10-3 mm2/s in chronic optic neuritis (p = 0.0002). The normal 
healthy controls had an ADC of 1.07 ± 0.1 x 10-3 mm2/s (p = 0.0088). FA was not measured. 
They postulate a similar axonal loss and Wallerian degeneration in chronic optic neuritis that 
increases ADC. In acute optic neuritis, there is accumulation of macrophages and 
lymphocytes but the myelin is intact, therefore ADC decreases. 
In summary, acute optic neuritis is associated with decreased ADC and chronic optic neuritis 
with increased ADC and MD, and decreased FA. 
 
2.7.3 Other applications of optic nerve diffusion 
Diffusion abnormalities have been described in other disorders. 
In a post-operative case of bilateral ischaemic optic neuropathy, Park et al showed restricted 
diffusion in both optic nerves with reduced ADC values of 0.425 x 10-3 mm2/s and 0.420 x 
10-3 mm2/s on the right and left respectively. They suggest using DWI in cases of post-
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surgical visual loss to detect posterior ischaemic optic neuropathy which is missed on 
funduscopy  [94].  
Verma et al have shown restricted diffusion in an optic nerve affected by posterior ischaemic 
optic neuropathy from aspergillus infection. They too demonstrate reduced ADC of 0.635 x 
10-3 mm2/s, but the adjacent nerve had elevated ADC of 1.7 x 10-3 mm2/s presumably due to 
vasogenic oedema  [95]. Similar findings of restricted diffusion have been reported by Chen 
JS et al, Caquil C et al and Al-Shafai LS et al [24, 96, 97].  
Glaucoma is a common cause of optic neuropathy. Recent studies using DWI and DTI have 
demonstrated degeneration of the optic pathway from the optic nerve to the visual cortex. In 
an animal model of glaucoma, Hui et al have shown increasing radial diffusivity and 
decreasing FA of the optic nerve as the disease progresses [98]. The implication is that as 
axonal degeneration develops from long standing glaucoma, anisotropic diffusion decreases. 
Axial diffusion was not affected because the 10% of axonal loss did not impact on it.  
Zhang et al using DTI have shown decreased FA (0.39 vs. 0.54, p<0.001), increased radial 
diffusivity (1.5 vs. 0.99, p < 0.001), increased axial diffusivity (2.83 vs. 2.48, p = 0.009) and 
increased MD (1.94 vs. 1.48, p<0.001) when compared to normal controls [81]. The benefit 
is examination of the status of the optic nerve in glaucoma patients with opaque optic media. 
As an indicator of glaucoma severity, Dai et al imaged the brains of 25 glaucoma sufferers 
using 3T MR DTI and ‘b’ value of 800 s/mm2 along 30 directions and compared that to 25 
healthy age-matched controls [25]. The chiasm and bilateral optic radiations of glaucoma 
patients showed significantly reduced FA (chiasm 0.16±0.02 versus 0.20±0.02 p < 0.05) (left 
optic radiation 0.40±0.03 versus 0.46±0.03, right optic radiation 0.38±0.04 versus 0.44±0.04, 
p<10-3) when compared to the healthy controls. Optic radiation radial diffusivity was 
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decreased compared to controls (p< 0.05). No significant differences were noted in the axial 
diffusivity and the mean diffusivity between the glaucoma patients and healthy controls. 
Optic chiasm FA was negatively correlated and optic radiation radial diffusivity was 
positively correlated with glaucoma stage. The authors conclude that these parameters could 
serve as non-invasive markers of disease severity.  
In optic neuritis, there is perivascular lymphocytic infiltration, multifocal demyelination, and 
reactive astrocytosis [30]. Iwasawa et al (1997) have demonstrated decreased diffusion in 
acutely inflamed optic nerves with reduced ADC values, but no comparisons were made 
between perpendicular and parallel diffusion. One may hypothesize a similar diffusion 
abnormality of the optic nerves in cryptococcal induced visual loss if the predominant 
disorder is optic nerve infiltration. In the acute optic neuritis model, the ADC values along 
the parallel axis will be decreased and FA values will also be reduced due to the presence of 
inflammatory cells and fungi. One may also expect a decrease in the parallel to perpendicular 
diffusion ratios with AI and FA reduced due to greater isotropic diffusion. The chronic optic 
neuritis model from myelin and axonal loss will not apply in the acute setting of CM. In 
chronic optic neuritis there is elevated ADC and reduced FA.  
 
2.8 Papilloedema 
2.8.1 Pathophysiology of Papilloedema 
In papilloedema from any cause of elevated intracranial pressure, disc swelling results from 
axoplasmic flow stasis. There is entrapment of the optic nerve axons at the lamina cribrosa 
due to elevated intracranial pressure transmitted along the subarachnoid space to the junction 
of the globe and retrobulbar optic nerve. Axoplasm and metabolic products accumulate at the 
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optic disc resulting in hyperaemia and elevation of the disc. The retrobulbar optic nerve is 
structurally normal in papilloedema, but little is known about its functional status.  
The leakage of axoplasm into the subretinal layer is partially responsible for Paton’s lines. 
The central location of the central retinal vein within the optic nerve makes it susceptible to 
compression. Loss of spontaneous venous pulsations is due to pressure changes between the 
peri-optic CSF and the intra-ocular pressure and central retinal vein compression. 
Longstanding venous compression causes nerve fibre layer oedema, exudates and retinal 
haemorrhage.  Compression of the central retinal artery is responsible for hypoxia, gliosis and 
finally optic atrophy. The choroidal folds are a mechanical outcome from stretching that 
occurs following optic nerve sheath distension [7] (Figure 14).  
 







2.8.2 Predicted diffusion parameters of Papilloedema 
One can speculate that the effect of elevated pressure on the optic nerve as occurs in 
papilloedema, will be increased displacement of water molecules along the nerve and 
therefore increased axial diffusion - as in circumferentially squeezing toothpaste. Higher 
ADC values will occur in the parallel direction such that AI will increase. One may also 
speculate that the FA of diffusion along the optic nerve should be unchanged or increase 
since myelin sheath and axons are preserved in the acute situation. However if secondary 
axonal degeneration occurs then diffusion parameters will be similar to chronic optic neuritis 
with high ADC values and low FA. 
2.9 The Optic nerve Compartment Syndrome 
2.9.1 Pathophysiology of the Optic nerve Compartment Syndrome 
The compartmentalisation of the peri-optic SAS has become of interest due to the persistence 
of papilloedema and visual loss in patients with idiopathic intracranial hypertension (IIH) 
who have a functioning lumbo-peritoneal shunt [99, 100]. Furthermore, the presence of 
asymmetrical papilloedema in IIH and IIH without papilloedema has both required 
explanation [101]. Killer et al have demonstrated the compartmentalization of the peri-optic 
SAS in patients with IIH [66]. They performed CT-cisternography in 3 patients with 
asymmetrical papilloedema and were able to demonstrate impaired influx of contrast loaded 
CSF (CLCSF) into the orbital segment of the nerve. In 2 patients, CLCSF entered the SAS of 
the optic nerve only within the optic canal, but not within the intra-orbital segment of the 
nerve. Impaired flow occurred at the intracanalicular portion in these patients. In the 3rd 
patient with IIH, CLCSF entered the orbital portion of the SAS of the nerve, up to 10 mm on 
the right and 5 mm on the left. The site of ‘blockage’ depends on the structure and amount of 
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septae and trabeculae within the peri-optic SAS.  Biological evidence for the 
compartmentalisation of the peri-optic SAS has come from concentration gradient 
measurement of brain-derived lipocalin-like prostaglandin D synthase (L-PGDS) in the spinal 
CSF and peri-optic SAS, where much greater concentrations are found [102]. Either flow 
within the peri-optic space is much slower or additional production of L-PGDS occurs there.  
The compartment syndrome results from increased pressure within a confined compartment 
due to swelling of its constituents. There is subsequent compression of vital structures within 
the compartment with subsequent vascular compromise (arterial and venous) and nerve 
compression. 
The optic nerve compartment syndrome is dependent on a number of pathophysiological 
mechanisms [66, 103]. The smallest diameter of the peri-optic SAS is within the optic canal 
(Figure 15). It is however not the only site of compression. The fact that blockage has also 
been demonstrated in the orbital portion suggests the importance of the dura and the 
subarachnoid structures viz. the trabeculae and septae [65]. The compartment syndrome in 
the setting of anterior ischaemic optic neuropathy AION and anterior optic neuritis and 
glaucoma suggests that inflammation (arachnoiditis) also plays a role [69, 104, 105]. The 
presence of inflammatory cells also contributes to the closing of the arachnoid apertures 
(spaces between trabeculae and septae) and blockage of meningeal lymphatics [65]. 
Furthermore, there is the toxic effect of reduced clearance of the CSF. L-PGDS is 
neuroprotective to astrocytes, but modulates inflammatory processes and enhances apoptosis. 
Damage to the mitochondria especially in the bulbar portion of the nerve is associated with 
demyelination and visual loss. [99] 
Orgul’s use of the term compartment syndrome relates to Glaucoma [106]. Remodelling of 
the lamina cibrosa pores that become more slit like cause compression of the optic nerve 
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axons as they pass through the lamina cribrosa. He postulates this as the obstruction that 
causes optic nerve dysfunction even in the presence of normal intra-ocular pressure.  
Burde and Kerr use the term to describe the compression of the optic nerve axons that are 
hypoxic and swollen within a disc at risk [107, 108]. The crowding of swollen axons through 
this small disc results in compression and further hypoxia from compressed vasculature in the 
setting of AION. 
 
Free bidirectional flow of CSF between the peri-optic SAS and intracranial SAS has been 
taken for granted. CSF is produced in the ventricles and by bulk flow reaches the peri-optic 
SAS. However no hydrodynamic theory explains the reversal of flow in the peri-optic SAS 
back towards the brain against the volume gradient. The cul-de-sac structure of the optic 
nerve sheath suggests that other mechanisms must operate to allow drainage of CSF from the 
peri-optic space. One theory is drainage into the orbit and has been demonstrated in animal 
studies by leakage of contrast agents and radio-isotopes into the orbit [109]. The more 
popular theory is by drainage into the optic nerve sheath lymphatics [110, 111]. 
 




Figure 15 shows the schematic representation of the CSF spaces surrounding the optic chiasm 
(intracranial CSF space) (A) and the CSF surrounding the optic nerve (orbital CSF space) 
(B).  
CSF flows from intracranial (A) into the SAS of the optic nerve (B). The SAS of the optic 
nerve is most narrow in the canalicular region (C). The intraorbital segment of the SAS is 
characterized by broad septae (D), whereas the retrobulbar segment is characterized by small 
trabeculae (E). Due to the CSF volume gradient the direction of flow is directed from the 
intracranial SAS to the orbital SAS. 
2.9.2 The Optic nerve Compartment Syndrome and Cryptococcal Meningitis 
IIH and CM share key characteristics. Both conditions present with raised intracranial 
pressure, swollen optic discs, raised intracranial pressure headaches, impaired CSF re-
absorption and lack of hydrocephalus. Killer et al explain the asymmetrical papilloedema in 
IIH to the anatomy of the subarachnoid trabeculae, septae and pillars that limit the transfer of 
the intracranial pressure to the laminar cribrosa asymmetrically [66]. One may speculate that 
a similar mechanism operates in CM.  However, in CM in addition to the markedly elevated 
intracranial pressure there is also plugging of the peri-optic CSF space by cryptococcal fungal 
elements (fungal yeasts and fragments of the polysaccharide capsule). The result would be 
immense compression of the optic nerve at sites of blockage. We speculate that the resultant 
axoplasmic stasis would cause optic nerve dysfunction and when axoplasmic stasis is severe 
and reaches the optic nerve head, papilloedema will result. 
The literature abounds with anecdotal evidence for and against the papilloedema and optic 
neuritis models of visual loss in CM. Unfortunately, clarity is lacking and therefore 
appropriate preventative strategies and management protocols for visual loss are vague. 
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Furthermore, the optic nerve compartment syndrome in CM has not hitherto been 
investigated. Epidemiological data, immunological data, neuro-imaging, VEP and HVF of 
CM induced visual loss need clear and precise documentation. The use of objective and 
reproducible investigational tools to study visual loss in vivo and determine the pathogenesis 
by comparison with established causes of papilloedema and optic neuritis need addressing. 
The advances made by DWI and DTI of the optic nerve in multiple sclerosis must be 
exploited in CM and has been the motivation for their use in this study. Antiretroviral therapy 
and antifungal therapy has made huge strides in the survival of CM patients. Consequently, 
prevention and treatment of the devastating disability of blindness in survivors is of 














CHAPTER 3 AIMS 
3.1 To clinically, electrophysiologically and biochemically describe optic nerve dysfunction     
in cryptococcal-induced visual loss according to  
3.1.1 Frequency of visual disturbance 
3.1.2 Severity of visual disturbance 
3.1.3 Mode of onset of vision loss 
3.1.4 Relationship to degree of immunosuppression and treatment 
3.1.5 CSF findings 
 
 
3.2 To optimise DWI and DTI imaging of the optic nerve and thereby obtain standard and 
reproducible imaging protocols. 
 
 
3.3 To devise a mathematical model that separates optic nerve diffusion from surrounding 





3.4  To propose a probable pathogenesis of Cryptococcal induced visual loss by 
investigating and comparing the following 
 
 
3.4.1 Quantitative DWI and DTI of the optic nerves in patients with cryptococcal 
induced visual loss, using protocols obtained in Aims 2 and 3 above and 
comparing to normal controls. 
 
3.4.2 Comparison of routine FSE, DWI and DTI of the optic nerves in patients with 
cryptococcal meningitis stratified into 2 groups with normal and abnormal 
visual acuity. 
. 
3.4.3 Comparison of FSE, DWI and DTI of the optic nerves in patients with 
cryptococcal induced visual loss, to patients with papilloedema (IIH, 
malignant HPT and RICP) and optic neuritis i.e. optic nerve disorders 








CHAPTER 4 PAPER 1 
New insights into the pathogenesis of Cryptococcal-induced visual loss using Diffusion-
Weighted Imaging of the optic nerve: 
 The paper addresses aims 3.1 (3.1.1, 3.1.2), 3.2 and 3.4 (3.4.1, 3.4.2) 
 A Moodley is the main author 
 It was published in the journal, Neuro-ophthalmology in October 2012. 
This paper describes in detail the optic nerve diffusion technique used in the study. The 
results from 29 asymptomatic controls (9 HIV positive and 20 HIV negative) were compared 
to that of 52 HIV infected patients with culture confirmed cryptococcal meningitis.  
A 1.5T Philips Gyroscan was used for magnetic resonance (MR) diffusion-weighted imaging 
(DWI) and diffusion-tensor imaging (DTI) of the brain and optic nerves using the coronal 
oblique technique for each nerve as previously reported [49].   Diffusion gradient of b = 1000 
s/mm2 was selected and fat saturated (SPIR) single shot EPI using SENSE without cardiac 
gating was used. EPI was acquired using echo time (TE) = 93 ms, relaxation time (TR) = 
3000 ms, 180 mm field of view (FOV), matrix = 112 x 128 and 4 mm slice thickness. DTI 
was obtained in 15 directions and longitudinal, axial and mean diffusivity values were 
selected for analysis. FA maps were computer generated using the Interanova Release 11.2.1 
version software. 
Visual loss (best corrected visual acuity < 6/9) was detected in 34.6% of patients with 
cryptococcal meningitis and in 9.6%, visual loss was profound (<6/60). Elevated CSF 
pressure (> 20cmCSF) was found in 69% of patients whereas swollen optic discs was present 
in only 25%. Patients with swollen discs and decreased vision accounted for 17.3%. Patients 
were more likely to have impaired vision with elevated CSF pressure than with swollen discs. 
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The optic nerve and optic nerve sheath diameters were similar in the healthy control group 
and in the CM group regardless of CSF pressure.  
Diffusion studies suggested a tendency towards elevated ADC and lowered FA but this needs 
further investigation. The implication is disruption of the longitudinally arranged axons and 
myelin sheath early in CM. 
The possibility of compression of the optic nerves due to elevated CSF pressure somewhere 
between the lamina cribrosa and optic canal is discussed. A discussion of the different models 
of visual loss in CM is presented and the role played by a possible optic nerve compartment 
syndrome is entertained. 
The frequency and severity of visual loss in CM are described. The optic nerve diffusion 
method is described in detail. Quantitative DWI and DTI optic nerve diffusion parameters are 
obtained for patients with CM. Comparisons are made between patients with normal and 
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ABSTRACT 
Despite a successful antiretroviral drug rollout in South Africa, cryptococcal)rtduce visual loss co tinues to be 
a major complication of cryptococcal meningitis. Preventive measures ar lacking ue to poor und;rstanding 
of its pathogenesis. Optic nerve diffusion has shown some promise.inin: estig ting inflammatory and axonal 
changes of the optic nerve in vivo. The lack of post-contrast enha cement'"o Tl magnetic resonance imaging 
(MRI) and signal changes on T2 MR1 with slightly increase~.p!?irent "ffusion coefficient and reduced frac-
tional anisotropy on diffusion imaging suggest that essm -related effects are th dominant mechanism over 
inflammation and that there is early untested evidence of'a comp~ment S,yndwme rather than papilloedema 
as the main contributor. 
KEYWORDS: Apparent diffusion coefficient, G mpartme t-synqrome, Cryptococcal meningitis, Fractional 
anisotropy, Optic nerve diffusion 
INTRODUCTION 
In South Africa, cryptococcal 111.1;ningiti (CM) is a 
common opportw1istic infection in se er ly immu-
nocompromised hum~ - unodeficiency virus 
(HIV)-infected patients. Despite t e efficient n ational 
antiretroviral rollout program, t e incidence o CM 
has not declined. 1 CM was the initial definin illness 
in the acquired im une deficiency synd~e (AIDS) 
in 84% of pa tients, an in 50% of HIV-infected patients 
neurological abnormalit" es were detected.2 Visual loss 
is common and is reported in 35--52.6% of patients 
w ith CM. Visual loss continues to deteriorate in 17.3% 
despite antifungal therapy and in 3.7% of patients 
follows commencement of antifungal therapy, which 
alone is insufficient in reversing vision loss.3 Visual 
recovery is unpredictable and requires early and 
effective adjunctive therapy to prevent or reverse the 
frequent and sometimes catastrophic loss of vision. 
Appropria te interventional therapy can only be 
identified and implemented once the pathophysiology 
Received 07 june 2012; accepted 15 June 2012 
of vision Joss in CM is welltmderstood. Unfortunately, 
there are conflicting reports concerning its patho-
nysiology and standard treatment p rotocols are 
disappointingly lacking. 
Rex et al.4 in 1993 postulated a dual mechanism 
of vision loss. The first mechanism was that of rapid 
visual loss early in the disease or soon after commenc-
ing treatment, u sually within 6 days. Optic neuritis 
was the postula ted pathogenic mechanism due to 
fungal infiltra tion of the nerve and ensuing inflam-
mation. Catastrophic visual loss in such patients was 
described as developing w ithin 12 hours. The second 
mechanism was slow visua l loss, due to papilloedema 
from chronically elevated cerebrospinal fluid (CSF) 
pressure that developed over several weeks. 
These mechanisms may not be mutually exclusive 
and one that incorporates both theories is also 
conceivable. We performed an in vivo study that 
investigates the pathogenesis of visual loss by 
using optic nerve diffusion on magnetic resonance 
imaging (MRI). Diffusion of water molecules within 
Correspondence: Anand Mood ley, Department of Neurology, Greys Hospital, Private Bag X9001, Pietermaritzburg, 3200 South Africa. 
E-mail: anand .mood ley@kznhealth.gov.za 






Optic Nerve Diffus ion in Cryptococcal Induced Visual Loss 187 
the optic nerve is anisotropic due to the longitudinal 
orientation of axons and intact myelin.5•6 Water diffuses 
preferentially along the longitudinal/ axial plane rather 
than the perpendicular I radial plane of the optic nerve. 
The quantitative entities that describe optic nerve 
diffusion are apparent diffusion coefficient (ADC), 
which can be measured in the orthogonal p lanes 
and obtained on d iffusion-weighted imaging (DWI), 
mean diffusivity (MD), a scalar quantity obtained on 
diffusion tensor imaging, and fractional anisotrop y 
(FA). FA describes the directional diffusion of water 
molecules within the nerve occurring preferentially in 
a longitudinal direction. FA ranges from 0 to 1 where 
0 represents isotropic diffusion, which is equal in all 
directions and 1 represents anisotropic diffusion, which 
is preferential diffusion in one direction. The normal 
value obtained for the optic nerve is 0.4-0.5, suggesting 
preferential diffusion of water molecules in the axial 
rather than the radial plane in optic nerves.7 
Optic nerve diffusion measurement has been shown 
to be of benefit in acute and chronic optic neuritis in 
multiple sclerosis7 •8 For example, Naismith et at.7 
in their cohort of acute optic neuritis demonstrated 
decreased ADC values in the axial plane due to the 
presence of inflammatory cells tha t supposedly restrict 
axial diffusion. FA values were also decreased due to 
greater isotropic diffusion from disruption of the axons 
and myelin. Hickman et a!} on the other hand, dem-
onstrated increased mean diffusion for similar reasons 
of disn1ption of cellu lar integrity; however, no differ-
entiation was made between axial and radial diffusion. 
Their cohort comprised patients with a remote history 
of optic neuritis (12 months) and resultant optic atrophy. 
In optic neuropathy from glaucoma, Engelhorn et a l.q 
have shown increased radial d iffusion and decreased 
FA of the optic nerve consistent with axonal disruption. 
Furthermore, Wang et al. 10 demonstrated increased 
radial diffusion, unaffected axial d iffusion, and reduced 
FA in subacute ischaemic optic neuropathy. The ben-
efits of optic nerve diffusion as an experimental tool are 
increasing. The effect of papilloedema on optic nerve 
diffusion, however, is not described. 
In this study, we aimed to firstly compare optic 
nerve diffusion in patients with CM to that of a healthy 
control population and secondly, to correlate clinical 
parameters (vision loss, elevated CSF pressure, and 
disc swelling) with imaging parameters (ADC on DWI, 
and MD on diffusion tensor imaging [DTI], FA, and 
anisotropic index). We postulated that an increase in 
ADC and/ or MD and a reduction in FA might suggest 
axonal disruption. Preferential reduction in axial diffu-
sion might suggest optic nerve infiltra tion. Where axial 
and radial diffusion are equally affected, the anisotropy 
index should be similar to the control group, a scenario 
one would expect in papilloedema or a compartment 
syndrome. For analysis of the axial and radial diffusion, 
the anisotropic index was calculated as a ratio of the 
axial diffusion to the mean radial diffusion. 
© 20 12 lnforma Healthcare USA. Inc. 
MATERIALS AND METHODS 
The study was approved by the Greys Hospital and 
the University of KwaZulu Natal ethics committees. 
Informed consent was obtained from 52 culture positive 
CM patients within 4 weeks of disease onset. Patients 
were consecutively recruited between February 2008 
and January 2011 and excluded if they were co-infected 
with tuberculosis, toxoplasmosis, progressive multifocal 
leucoencephalopathy, bacterial meningitis, or suffered 
any other central nervous system space-occupying 
d isease such as lymphoma. Patients underwent full 
neuro-ophthalmological evaluation and examination 
of immLme status and were subjected to MRl, DWI, 
and DTI of the brain, orbi ts, and optic nerves, using 
standard and modified imaging protocols on a Phillips 
1.5-Tesla Gyroscan magnetic resonance scanner. ADC 
using DWI, MD and FA using DTI, and an anisotropic 
index of axial diffusion to rad ial diffusion were com-
pared between groups and to a sample of 29 healthy 
volunteers with normal visual acuity. The optic nerve 
d iffusion results are presented. 
Unlike the zonal oblique multislice echo planar imag-
ing (ZOOM-EPI) method used by Wheeler-Kingshott 
eta!./ we opted for separate imaging of each optic nerve 
in the coronal plane (Figure 1). The axial and rad ial axes 
of ead1 nerve were first obtained, followed by 5 coronal 
oblique slices perpendicular to the long axis of the nerve 
within the orbit. The i.ntracanalicular portion of the 
nerve was avoided to minimize susceptibility artifacts. 
Fat-saturated single shot echo planar in1aging (EPI) 
using sensitivity encoding (SENSE) without cardiac 
gating was used. To allow for localization of the nerve 
on the BO image, fluid attenuation inversion recovery 
FlGURE 1 MRI T2 axial view of the optic nerve with selection 
of coronal slices shown. Slices are selected in a coronal oblique 
plane perpendicular to the orientation of the optic nerve, which 
is selected on a T2-weighted axial image. The coronal slice 
with best visualisation of the optic nerve is selected on OWl 
and OTI for further analysis. OW l = diffusion-weighted image; 
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(FLAIR) was not used. A higher B1000 gradient was 
used to overcome the influence of the surrounding CSF 
within the optic nerve sheath on the optic nerve diffu-
s ion. To minimise movement a rtefact, the patient was 
asked to lie comfortably and focus on an orange sticker 
p laced directly in line of their central field of view dur-
ing DWI and DTI. 
During analysis, a region of interest (ROI) of 2 x 2 p ix-
els was placed centrally on the optic nerve on the slice 
with best optic nerve visualization (Figure 2)-usually 
slice 2 or 3. ADC was obtained in the axial and radial 
p lanes. The mean diffusivity was a scalar average of 
the 3 ADC values obtained in the x, y, and z planes. 
The DTI was obtained in 15 directions; however, only 
axial, radial, and mean diffusivity values were selected 
for an alysis. In addition to the fractional anisotropy 
obtained from DTI (Figure 3), an anisotropic index was 
calculated from both the DWI and DTI using the for-





= radial d iffusion in the other two 
orthogonal axes. 
Statistical analyses were performed using OpenStat 
2008. All measures for the left and right eyes were sub-
mitted to a two-way analysis of variance (ANOVA). As 
no significant differences were noted between the eyes, 
the mean values for both eyes are presented. 
RESULTS 
All 52 cryptococcal meningitis patients were HIV posi-
tive and culture positive for Cryptococcus neoformans. 
Of the 29 healthy controls, 9 were HIV positive and 20 
were HIV negative. The values of ADC, MD, FA, and 
anisotropic index for HIV-positive versus HIV-negati.ve 
controls showed no significant difference and will be 
presented as a mean for the groups combined. 
None of the 52 CM scaru1ed showed any optic nerve 
signal change on Tl, T2, T2 FLAIR, and T1 post-contrast 
images. 
Table 1 shows the demographic data and clinical 
parameters of the 52 CM patients. Of these, 34.6% of 
patients had decreased best corrected visual acuity 
(BCVA) of ~6/9 on the Snellen chart. Only 5 patients 
had profOLmd vision loss of ~6/60, but none of these 
developed catastrophically within 12 hours. Sixty-nine 
percent of all CM patients had elevated CSF pressure 
and 25% had swollen d iscs. Decreased vision was asso-
ciated with elevated CSF pressure in 26.9% and 15.4% 
of patients had all of impaired vision, elevated CSF 
pressure and swollen d iscs. Alll3 patients with swollen 
discs h ad bilateral swelling. 
There was no significant difference in optic nerve 
sheath d iameters among the healthy control group, and 
the CM patients with normal and with elevated CSF 
p ressure. Similar optic nerve diameters between those 
groups were also documented and suggest no optic 
nerve infiltration or oedema (Table 2). 
FIGURE 2 ADC images of 61000 images showing ROI of 2x2 
pixels on optic nerve. (A) axial diffusion; (B, C) radial diffu· 
sion; (D) mean d iffusion. ADC =apparent diffusion coefficient; 
RO I = region of interest. 
FIGURE 3 Coronal s lice of fractional anisotropy on DTI, show-
ing ROI on the optic nerve. DTI = difh1sion tensor imaging; 
ROI = region of interest. 
In 6 patients, the optic nerves were poorly visu-
alised due to susceptibili ty and movement artefact. 
Optic nerve diffusion was therefore only analysed in 
46 patients. Thirty-five patients had elevated CSF pres-
sure and 11 patients had normal CSF pressure. The 
average CSF pressure was 34cm ~0 (range 21-50cm 
H20) in the elevated CSF pressure group and 14 em Hp 
(range 7-20cm H
2
0) in the normal pressure group. The 
Analysis of variance of ADC, FA, a nd the anisotropy 
index showed no significant differences between the 
normal and elevated CSF pressure groups or the normal 
healthy volunteers (Table 3). Graphs 1 and 2, however, 
show a tendency towards a high ADC and low FA in the 
CM patients with elevated pressure. 
Only 5 patients presented w ith severe vision loss of 
6/60 or worse, 2 with symmetrical loss of vision, 2 with 
asymmetrical loss of vision, and 1 with wlilateralloss of 
vision. None had the catastrophic vision loss described 
by Rex et al:' and none developed after the commence-
ment of anti fungal therapy. The analysis of variance of 
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TABLE1 Demographics and incidence of vision loss, elevated 
CSF ~ressure, and swollen discs. 
Age of 29 controls 
Age of 52 CM patients 
Healthy controls, Males 
Healthy controls, Females 
CM patients Males 
CM patients Females 
CM patients with swollen d iscs 
CM patients with decreased vision 
CM patients with VA $ 6/60 
CM patients with elevated pressure 
CM patients with swollen d iscs and 
decreased vision 
CM patients with swollen d iscs and 
elevated pressure 
CM patients with decreased vision 
and elevated pressure 
CM patients with decreased vision, 
swollen discs, and elevated pressure 
CM patients with normal vision, 





































Note. CM = cryptococcal meningitis; VA= visual acuity. 
TABLE 2 Comparison of optic nerve and optic nerve sheath 
d iam eters. 
Control 
CM with normal 
CSF pressure 
CM with elevated 
CSF Pressure 
Mean optic nerve 
sheath diameter in 
mm (range) 
6.03 (5.4-7) 








p-value 0.152 0.451 
Note. CM = cryptococca l meningitis; CSF =cerebrospinal flu id. 

















GRAPH 1 ADC and MD in CM normal and elevated pressure 
and controls. CM = cryptococcal meningitis; ADC = apparent 
diffusion coefficient; MD = mean diffusivity; OWl = diffusion-
weighted imaging; DTI = diffusion tensor imaging. 
ADC, FA, and the anisotropy index showed no signifi-
cant d ifferences between any of the four groups viz. the 
normal vision with CM, decreased vision of s6/9 with 
CM, decreased vision of s6/60, and the normal healthy 
control w ith normal v ision (Table 4). 










CMNormal CM Control 
Pressure Elevated Healthy 
Pressure Group 
GRAPH 2 FA in CM normal pressure, CM-elevated pressure, 
and controls. CM = cryptococcal meningitis; FA = fractional 
anisotropy. 
DISCUSSION 
Cryptococcal meningitis continues to be a common 
opportunistic infection amongst severely immuno-
compromised HIV-infected patients in South Africa 
despite the availabi lity of antiretroviral therapy. Poor 
compliance of antiviral drug therapy and the fai lure 
of voluntary testing are major setbacks.' The ongoing 
pandemic of HIV infection and opportunistic infections, 
notably CM, means appropria te and early measures 
need to be taken to prevent impending blindness. By 
using d iffusion-weighted imaging of the optic nerve we 
h ave attempted to elucidate the pathogenesis of cryp-
tococcal induced visual loss with the aim of preventing 
blindness by goal-directed intervention. 
Studies supporting and opposin g the mechanisms 
of optic neuritis and papilloedema have been man y 
but mostly anecdotal. The inflammatoty (optic neuritis) 
model of visual loss was made popular by many authors 
in the past by showing visual improvement with corti-
costeroid therapy and demonstrating active inflamma-
tion and necrosis of the optic nerve and optic chiasm on 
histology.3•11•12 Strong evidence for optic nerve infiltration 
also came from a case report of a patient w ith centrocae-
cal scotomata on visual field testing.13 The importance 
of identifying an optic neuritis model ensures that anti-
in flammatory therapy fea tures early in the intervention 
of CM to p revent blindness. Alternatively, the raised 
intracranial p ressure (papilloedema) model was sug-
gested by the accompanying constricted visual fields and 
enlarged blind spot in these patients and the beneficial 
response to serial lwnbar ptmctures, ventriculoperitoneal 
shunts, a.nd lumbar peritoneal shu.nt.1 ..... 16 Such evidence 
together with benefit from optic nerve sheath fenestra-
tion favours strategies that lower intracranial p ressure 
to prevent and treat blindness due to the infection.17 The 
likelihood of a combination of both models with or with-
out a compartment syndrome is also conceivable. 
None of the 52 cryp tococca l meningitis patients 
scanned showed any optic nerve signal change on Tl , 
T2, T2 FLAIR, or T1 post-contrast image. The absence 
of signal change reflects a paucity of inflammatory 
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TABLE 3 Quantitative parameters of imaging and CSF pressure. 
ADC using OWl X MD using DTl X w~] Anisotropy 
index us ing OWl 
Anisotropy index 
using DTl 10~3 mm2/s (± SD) mm2/s (± SD) FA(±SD) 
CM normal pressure 
CM elevated pressure 
Control healthy group 
1.18 (± 0.34) 1.18 (± 0.37) 0.41 (± 0.1) 
0.37 (± 0.13) 









1.26 (± 0.43) 1.2 (± 48) 
1.23 (± 0.41) 1.22 (± 0.34) 
p~value 0.841 0.972 0.517 
Note. CM = cryptococcal meningitis; ADC =apparent diffusion coefficient; DWT = diffusion~weighted imaging; OTT = diffusion tensor 





axial d iffusion and /..2, /..3 =radial diffusion . 
TABLE 4 Quantitative parameters of imaging and visual acuity. 
ADC using OWl x MD using DTI x 10~3 Anisotropy index Anisotropy index 
10~3 mm' /s (±SO) mm' /s (± SD) FA(±SD) using OWl using OTT 
CM normal vision 1.24 (± 0.29) 1.13 (± 0.32) 0.38 (± 0.09) 1.86 1.67 
CM decreased vision 6/9 and 
below 
1.21 (± 0.39) 1.28 (± 0.33) 0.36 (± 0.1) 1.65 1.78 
CM severely decreased vision 
6/60 and below 
1.24 (± 0.34) 1.38 (± 0.34) 0.44 (± 0.11) 1.20 1.88 
Healthy control group 
p~value 
1.23 (± 0.41) 
0.995 
1.22 (± 0.34) 
0.566 




Note. CM = cryptococcal meningitis; ADC = apparent diffusion coefficient; DWI = diffusion~weighted imaging; DTI = diffusion tensor 
imaging; MD= mean diffusivity; FA= fractional anisotropy given as a11 index from 0 to 1. Anisotropic index= 2/..,/(/..2 + /..3), w here /..1 = 
axial d iffusion and f..2, f..3 = radial diffusion. 
the organism, a situation that is reflected by minimal 
CSF changes in CM.2 Conversely, the absence of signal 
change suggests that no infiltration of the optic nerve 
occurs by the organism or inflammatory cells and that 
an optic neuritis model does not occur in early CM to 
explain visual loss. 
Testing of visual acuity is difficult in patients present~ 
ing acutely with CM for various reasons. Patients are 
confused, poorly attentive, systemically unwell, have 
raised intracranial p ressure, and frequently have 6th 
nerve palsies as false localising signs. Despite these 
setbacks, we were able to demonstrate visual loss as 
a complication in 34.6% of our patients, similar to the 
incidence previously reported by Moosa et at.2 All 
cases occurred within 4 weeks of disease onset and 
none afte r commencement of treatment. Severe visual 
loss occurred in 5 patients (9.6%), but none developed 
catastrophically within 12 hours as described by Rex 
et al.4 in their series. Conceivably, none of our patients 
complicated with optic nerve infiltration. Based on the 
mode of onset of vision loss, the optic neuritis model 
seems unlikely. 
Raised intracranial pressure was common, occurring 
in 69% (36/52) at an average of 34cm Hp, whereas 
disc swelling was noted in 25% of patients. Extremely 
high CSF pressures were noted in 7 patients at levels 
greater than 50cm ~0. Patients with decreased vision 
were more likely to have elevated CSF pressure and 
swollen discs; however, only 44% had both, suggesting 
that elevated CSF pressure impairs optic nerve func~ 
tioning not predominantly at the optic nerve head but 
somewhere between the lamina cribrosa and the optic 
canal. Despite elevated CSF pressure being common in 
cryptococcal meningitis, swollen optic discs is not as 
common (Figure 4). Only 23% of all patients had both 
elevated pressure and swollen discs. The possibility of 
pressure~related effects on the optic nerve exists but not 
at the optic nerve head. Whilst not entirely supporting 
the papilloedema model for vision loss, this lends sup~ 
port for the compartment syndrome occurring some~ 
where along the nerve, either at the optic canal or the 
intra-orbital segment of the nerve. 
The lack of any significant difference between the 
optic nerve sheath diameter in the cryptococcal men~ 
ingitis p atients w ith and without elevated CSF pres~ 
sure also supports the likelihood of a compartment 
syndrome (Table 2). The lack of appreciable swelling of 
the optic nerve sheath in the presence of elevated CSF 
pressure as confirmed on lumbar puncture is possibly 
d ue to a blockage proximally at the rigid optic canal or 
somewhere along the intra-orbital optic nerve where 
septae in the subarachnoid space have created a block~ 
age to CSF flow. 
Optic nerve diffusion has been found to be a useful 
tool in examining the optic nerve following acute optic 
neuritis and in the chronic setting in establishing axonal 
loss in multiple sclerosis.5•7•18•19 It is gaining momentum 
as an investigation al tool into the pathogenesis of other 
optic nerve disorders too, such as ischaemic optic neu~ 
ropath y and glaucoma 9 •10 This is the first study that 
looks at the pathogenesis of cryptococcal induced visual 
loss using DWI and DTI of the optic nerve. 
The technique used to scan the optic nerve was dif~ 
ferent to that of Wheeler- Kingshott's zonal oblique 
multislice echo planar imaging (ZOOM-EPI), lwasawa's 
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I Swollen Disc 
FIGURE 4 Relationships between CSF pressure, decreased vision, 
and swollen disc. CSF = cerebrospinal fluid. 
Chabert's non-Carr-Purcell-Meiboom-Gill fast spin 
echo sequence (non-CPMG FS£).5•6·19 We used a higher 
61000 gradient to eliminate CSF artefact rather than 
FLAIR, single-shot fast spin echo to limit the effect of 
motion and a coronal oblique slice to image the optic 
nerves separately. By not using FLAIR, identification of 
the optic nerve on 60 images was made much simpler. 
The MD values reported for healthy optic nerves in the 
studies of Wheeler-Kingshott et al.,6 Iwasawa et al.,5 and 
Chabert et al.2° range between 1.0 and 1.3 x 10-3 mrn2 Is 
and FA range between 0.4 and 0.6. The method we used 
revealed comparable va lues of 1.2±0.34 x lQ-3 mm2 /s 
for MD and 0.4 ± 0.12 for FA of healthy optic nerves. 
Axonal disruption within the optic nerve following 
optic neuritis is associated wi th an increase in ADC and 
a decrease in FA.19 Whilst no significant difference in 
MD or FA was found between the elevated and normal 
CSF pressure groups in cryptococcal meningitis (Graphs 
1 and 2 and Table 3), the tendency towards an elevated 
ADC and reduced FA suggests axona l disruption in the 
elevated CSF pressure group, implying tha t elevated 
CSF pressure and papilloedema do play an early role 
in vision loss in patients with cryptococcal meningitis. 
The similar anisotropy index in all pressure groups 
(Table 3) and all vision groups (Table 4) suggests that 
axial diffusion along the nerve is not preferentially 
affected in cryptococcal meningitis. Optic nerve infi l-
tration therefore seems unlikely as a plausible expla-
nation for visual loss in early cryptococcal meningitis, 
contrary to the widely accepted theory of Rex et al.4 
This tendency towards increased ADC and reduced FA 
needs to be confirmed in future studies by recruiting 
larger number of patients, using 3-Tesla MRI and by 
comparison to other causes of papilloedema. 
The lack of convincing evidence for either an optic 
neuritis or papilloedema model using optic nerve diffu-
sion suggests either that this is an unhelpful investiga-
tive tool for infective disorders affecting the optic nerve 
such as cryptococcal meningitis or that an optic nerve 
sheath compartment syndrome is the main mechanism 
by which visual loss occurs. The usefulness of optic 
© 2012 In forma Health care USA. Inc. 
nerve diffusion as an investigative tool in optic neuritis 
and ischaemic optic neuropathy has been well estab-
lished/.8·19 Killer et al.21 have adequately shown with 
computed tomography (CT) cisternography that the 
optic nerve sheath subarachnoid space is interrupted 
by septae and trabeculae and tha t in raised intracranial 
pressure as in idiopathic intracranial hypertension there 
is compartmentalisation between the intracranial and 
optic nerve sheath subarachnoid spaces. This theory 
sufficiently explains idiopathic intracranial hyperten-
sion with unilateral and asymmetrical papilloedema 
and cases without papilloedema. It is very likely that 
in patients with cryptococcal meningitis, entrapment 
of cryptococci by these septae and trabeculae that 
occur naturally causes obstruction to the free flow of 
CSF around the optic nerve and perhaps when sub-
jected to the raised intracranial pressure transmitted 
along the subarachnoid space results in a compartment 
syndrome. Such entrapment of cryptococci within the 
optic nerve sheath has been demonstrated in a patient 
who showed resolution of papilloedema and .improved 
vision following optic nerve sheath fenestration.17 The 
raised pressure on the nerve results in optic nerve dys-
function and morphological changes depending on the 
site of obstruction. Obstruction at the lamina cribrosa 
results in papilloedema, whereas that at the optic canal 
or along the intra-orbital nerve results in axoplasm 
stasis or venous congestion and resultant optic nerve 
dysfunction. The absence of signal changes in the optic 
nerve on MRI in patients with elevated CSF pressure 
and decreased vision makes axoplasm s tasis the more 
plausible. 
Pressure-related effects with a compartment syn-
drome seem to be the most attractive theory currently 
that explains the early loss of vision in cryptococcal 
induced visual loss and deserves further investigation. 
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CHAPTER 5 PAPER 2 
The impact of optic nerve movement on optic nerve and peri-optic CSF diffusion: 
 This paper addresses the aims 3.2 and 3.3 above. 
 A Moodley is the main author  
 It has been submitted to the journal, Magnetic Resonance in Medicine and awaiting 
review. 
The paper addresses the technique of optic nerve diffusion used in this study and compares 
the technique to that used by other investigators. We have used a 1.5 Tesla MRI scanner and 
a gradient of b1000. Fat saturation was included in the Diffusion sequence, but fluid 
attenuation was not. We have found that to be a useful way of identifying the optic nerve on 
the b0 images of the diffusion scanner. Furthermore, by not suppressing the CSF signal, we 
have been able to measure the diffusion parameters from the surrounding (peri-optic) CSF 
which differs from the optic nerve. Both DWI and DTI of the optic nerve were done using 
this technique. Findings are equivalent to those of other studies that use and do not use fat 
saturation and fluid attenuation. The peri-optic CSF shows higher ADC and MD values as 
expected but the anisotropic index indicates that the flow in the peri-optic CSF space is not 
isotropic. 
 
The study also measures the amount of optic nerve movement during a standard Diffusion 
study, both in the distance and area covered. Optic nerve tracking was done using single shot 
EPI and 20 snapshots of the nerve were taken in the 3 minute period of recording.  
66 
 
The optic nerve movement parameters were then correlated with optic nerve and peri-optic 
CSF diffusion parameters. No significant correlations were noted, indicating that 
macroscopic movement of the nerve has no significant impact on the microscopic movement 
of water molecules (diffusion) within the nerve and peri-optic CSF space.  
The impact of the non-suppressed CSF signal on optic nerve diffusion and peri-optic CSF 
diffusion was then analysed. Linear regression analysis of optic nerve and CSF diffusion 
parameters showed low R2 values with minimal statistical but no clinical or practical 
significance.    
We have been able to obtain standard and reproducible DWI and DTI imaging protocols of 
the optic nerve. No mathematical model was required to correct for the surrounding CSF 


































































(range) SCC SCC SCC SCC SCC SCC SCC SCC 
Total 
distance 
moved.  mm 
11.8 
0.16 -0.27 0.07 -0.003 -0.32 -0.16 -0.33 0.07 
(5.7 – 23.7) 




0.24 -0.16 0.08 -0.06 -0.28 0.15 -0.3 0.38 
(0.6-22.1) 
Displacement 
in the X-axis. 
mm 
2.1 
0.27 -0.10 0.18 0.15 -0.07 -0.03 -0.45 0.14 
(0.8-5.1) 
Displacement 
in the Y-axis. 
mm 
2.2 








































CHAPTER 6 PAPER 3 
Neurological, visual, and MRI brain scan findings in 87 South African patients with 
HIV-associated cryptococcal meningoencephalitis. 
 
 This paper addresses aims 3.1 (3.1.1, 3.1.2, 3.1.3, 3.1.4) 
 A Moodley and A Loyse are equally responsible for writing this paper.  
 The paper has been submitted to Clinical Infectious Disease and is awaiting review 
 
Eighty seven patients with culture confirmed CM underwent MRI scanning within 2 weeks of 
presentation. Eleven patients had a repeat scan at 1 month follow up. The neurological, visual 
and MRI findings of these patients are presented in this paper.  
In this cohort of 87 patients, the median CD4 count was 29 (IQR 12-69), 22% were on 
ARV’s at diagnosis and 6% had abnormal mental status. 71% had elevated intracranial 
pressure and the median opening pressure was 30cmCSF (IQR 18-42). The median fungal 
burden at MRI scanning of 26 patients was 4.71 log CFU/mL of CSF [3.58-5.64]. 
33/85 (39%) patients had an abnormal finding on neurological examination. 19 patients 
complained of diplopia, and 18/85 patients (21%) had cranial nerve (CN) palsies.  14/18 
(78%) CN palsies were VIth nerve palsies, of which seven were bilateral.  3/18 (17%) patients 
had VIIIth nerve palsies. 19/85 (22%) patients had abnormal coordination and, for the 78 
patients who were ambulant, 15/78 (19%) patients had an abnormal gait. 
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In 38/85 (48%) patients, a best corrected visual acuity measurement of <6/6 was found on 
examination of either eye on the day of MRI scanning.  In 31/38 (82%) patients the visual 
loss was bilateral.  
In 2/87 (2.2%) of patients, the MRI scan was reported as normal. There were 55/87 (63%) 
patients with cryptococcal related radiological lesions viz. enlarged VRS 31/87 (36%), 
pseudocysts 19/87 (22%), meningeal enhancement 24/87 (28%), enhancing nodules 23/87 
(27%), lacunar infarcts 12/87 (14%), cortical infarcts 5/87 (6%), cerebral oedema 14/87 
(16%) and hydrocephalus 2/87 (2%). Visual loss correlated with the presence of presumed 
cryptococcal-related lesions (p = 0.02) 
Paired scans show that brain swelling is not common early in CM and perhaps does not 
























































































































CHAPTER 7 PAPER 4  
Early Clinical and Subclinical Visual Evoked Potential and Humphrey’s Visual Field 
Defects in Cryptococcal Meningitis: 
 This paper addresses aim 3.1 (electrophysiological optic nerve dysfunction) 
 A Moodley is the main author 
 The paper was published in PLoS One, in December 2012 
We undertook a prospective study on 90 HIV sero-positive patients with culture confirmed 
CM. Seventy-four patients underwent visual evoked potential (VEP) testing and 47 patients 
underwent Humphrey’s visual field (HVF) testing.  
Decreased best corrected visual acuity (BCVA) was detected in 46.5% of patients. VEP was 
abnormal in 51/74 (68.9%) right eyes and 50/74 (67.6%) left eyes. VEP P100 latency was the 
main abnormality with mean latency values of 118.9 (±16.5) ms and 119.8 (±15.7) ms for the 
right and left eyes respectively, mildly prolonged when compared to our laboratory 
references of 104 (±10) ms (p<0.001). Subclinical VEP abnormality was detected in 56.5% of 
normal eyes and constituted mostly latency abnormality. VEP amplitude was also 
significantly reduced in this cohort but minimally so in the visually unimpaired.  
HVF was abnormal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The 
predominant field defect was peripheral constriction with an enlarged blind spot suggesting 
the greater impact by raised intracranial pressure over that of optic neuritis. Subclinical HVF 
abnormalities were minimal.  
Elevated CSF pressure resulting in a compartment syndrome possibly along the nerve within 
the orbit or at the optic canal seems the best explanation for optic nerve dysfunction 
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demonstrated on VEP and HVF. Early optic nerve dysfunction can be detected by testing of 
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Abstract 
Cryptococcal induced vis ua l lo ss is a devastat ing complication in survivors of cryptococcal mening itis (CM). Ea rly de tection 
is pa ramount in prevention and treatment. Subclinical o ptic ne rve dysfunct ion in CM has not hithe rto been investigated by 
e lectrophysio logica l means. We undertook a prospective study on 90 HIV sero-posit ive patients with cu lture confirmed CM. 
Seventy-fou r pat ients underwent visual evoked potent ial (VEP) test ing and 47 pat ients unde rwent Humphrey's visual fie ld 
(HVF) testi ng. Decreased best corrected visual acuity (BCVA) was detecte d in 46.5% of pat ients. VEP was abnormal in 51/ 74 
(68.9%) right eyes and 50/ 74 (67.6%) left eyes. VEP P1 00 latency was the main abnormality w ith mean latency values of 
118.9 (± 16.5) ms and 11 9.8 (± 15.7) ms fo r t he right and left eyes respectively, mildly prolonged when co mpared to our 
laboratory refere nces of 104 (± 1 0) ms (p < O.OOl). Subclinical VEP abnormality was detecte d in 56.5% of normal eyes a nd 
constituted mostly latency abno rmality. VEP amplit ude was also sig nifica ntly reduced in t his cohort but minima lly so in t he 
visually unimpaired. HVF was ab normal in 36/47 (76.6%) right eyes and 32/45 (71.1%) left eyes. The predominant fi e ld defect 
was peripheral co nstrictio n with an enlarged blind spot suggesting the greate r impa ct by raised intracranial pressu re over 
tha t of opt ic neurit is. Whether t his was due to papilloedema or a compartment syndrome is o pe n to further invest igation. 
Subc linica l HVF abnormali t ies were minimal and therefo re a poor screening test for early optic nerve dysfu nction. However, 
early optic ne rve dysfu nction can be detected by testing of VEP P1 00 latency, which may precede the onset of visual loss in 
CM. 
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Introduction 
Ctyptococcal meningitis (C ~ I) and other opportunistic infCctions 
in H l\1 infected patients continue to be a burden in developing 
countries despite established antiretroviral drug treatment pro-
grammes r 1] . i\ major cha llenge lacing satislactory managemem of 
CM is the late presentation of patients with advanced AIDS at in itia l 
presenta tion. Fifty percent of pa tients with C~I present with 
neurologica l complications, of which ,·isualloss is the most disabling 
in patients that recover f2l Visual loss is se,·erc, occurs early in 
infection and is recorded in up to 40% of patients [3 6]. 
Visual loss in cr-. [ is well documcmed, howe\'Cr the pa thogenesis 
remains controversial. Rex et a l. have suggested a dual n1echanis1n 
of early optic neuritis and late papilloedema resulting fi·om optic 
netYe infilt ration and raised imracran ial pressure respecti, ·cly [7]. 
1\evertheless, conflicting reports of the optic neuritis, papilloedema 
and the more recent compartment syndrome models abound in 
the literature [8 II]. i\ defi nitive model is still lacking but the 
compartn1cnt syndrome occurring along the nerve or at the optic 
PLOS ONE I www.plosone.org 
canal level seems most plausible [12, 13]. i\ better understanding of 
the pathogenesis of CI) lltococcal induced visual Joss will certainly 
provide bener guidance to management and prevention of 
bl indness in th is group. The recommended inten·cntion to pre,·ent 
visual loss is lowering of CSF pressure, either by serial lumbar 
punctures, in situ lumbar dra in or optic netYe sheath fenestration 
[8 , I 4--16). However the likelihood of optic nerve infilt ration and 
the benefit of corticosteroids ha,·e not been entirely excluded as 
treatment option as demonstra ted pa thologically by Corti et al 
that fungal infilt ration of the optic nerve docs occur and by De 
Schacht ct al of the benefi t of corticosteroids especia lly in the 
setting of imn1unc reconstitution [ 17 , 18]. 
T he Visual £, ·oked Potential (VEP) is reproducible and the 
P I 00 waveform is easily identified and analysed. Full field 
monocular pattern-reversal VEP is a useful test of prc-chiasmic 
optic nerve fu nction. VEP findi ngs of prolonged latency and 
reduced amplitude suggest optic nerve dysfunction, which in the 
sett ing of early ,·isual loss in Ci\I points to optic netYe inldtra tion. 





Chronic papilloedema may also have similar VEP changes but will 
not be expected to occur early in the disease. f urthermore, central 
and centrocecal scotomata early in Ci\ I. point to optic nerve 
dysfunction whereas a large blind spot and constricted field will 
suggest papilloedema related dysfunction. Automated Humphrey's 
Visual Field (HVF) is not operator dependent and qualitatively 
offers useful localization of visua l pathway dysfi.111ction. Its 
limitation however is in patients with severe visual loss who 
cannot be tested. T he electrophysiology of optic ncr..-e dysfunction 
in Ci\ I is poorly documented and whether it can contribute 
towards the discussion of pathogenesis and subclinical disease has 
not hitherto been explored. i\lwanza et al. ha, ·e demonstrated 
V EP abnormalities in 57% and 42% ofHIV infected patients with 
and without neurological symptoms, al though it is unclear what 
the burden of Ci\1 disease was in these patients ["! 9l 
The primary aim of this study was to establish the extent of the 
clectrophysiological disturbance within the optic nerve in patients 
with Ci\ 1 by exa mining VEP and comparing with automated 
HVF. T he detection of subclinical disease within the optic nerve 
by electrophysiological means could potentially identif)· pa tients 
most at risk of developing visual loss. Fun her correlation with the 
pat ients' in1n1unc status, visual acuity, optic disc appearance and 
CS F pressure was made. T he secondary a im was to dctcnninc if 
VEP and HVF could contribute to the optic neuri tis vs. 
papilloedema vs. compa rtment syndrome debate with regard to 
the pathogenesis of cryvtococcal induced visual loss. 
Materials and Methods 
Ethical approval was obtained from the University of KwaZulu-
Natal and Greys Hospita l ethics committees. Informed consent 
was obtained from 90 patients with Ci\ I, confi rmed on fu ngal 
culture, who were consecutively recruited from Februmy 2008 to 
j a nua1y 20 I I. Patients underwent , ·isual e,·oked potential testing, 
visual field testing, neuro-ophthalmological assessment and lumbar 
punctures, which formed pan of their routine work-up for chronic 
meningitis. Recru itment of patients occurred within 2 weeks of 
commencement of treatment and usually \\'ithin 4 \\'eeks of 
symptom onset of meningitis. CNS co-infection with tuberculosis, 
toxoplasmosis, syphilis or any other opportunistic infection, when 
identified , was an exclusion cri ter ion. ~ ~ck of co-opera tion by 
cnccphalopathic patients precluded VE P and HVF testing. Flash 
light emitting diode (LED) goggles VEP was done for 6 patients 
who could not fLxate due to severe visual loss or inattention . 
VEP recordings were obtained monocularly. Full field pattern-
reversal VEPs were elicited by checkerboard stimuli of large I 
degree (i.e. 60 min of arc) checks a nd detected using silver 
electrodes placed over the scalp in accordance with ISCEV 
guidelines [20]. The P I 00 la tency and peak to peak ::\80 P I 00 
ampliwde were considered for a nalysis. 
Automated H umphreys Visual Fields were performed using the 
30 2 SlTA standard protocol. Only pauern deviation fi elds that 
fulfilled acceptable reliability indices were included for analysis. 
Acceptable reliability indices of HVF were fi xa tion losses <33%, 
false negatiYes <33% and false positives < 33%. 
Stast istics 
Visual acuity, VEP latency and amplitude were dichotomized 
into abnormal and normal gro ups using standard norn1al 
references. A best COITectcd visual acuity of < 6/6 on the Snellen 
chan , VE P P I 00 la tency of > 114 ms and VEP l\80-P I 00 
amplitude of < I 0 ~ V were considered abnormal. A CSf opening 
pressure of :520 cmf-1 20 was considered normal. One sample t 
tests were used to compare mean latency and atnplitudc to 
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laboratory references. T ests for association between groups were 
analysed using a Chi Square test or Fisher's exact test as 
appropriate. Statistical analysis was done in ST AT A, version 12. 
Results 
All 90 paticms recruited were HTV sero-positive and co-infected 
wit h CryjJ/ococrus ne'!fonnans. All \\'Crc black African, 50 (55.6%) were 
males and the mean age oft he cmire group was 33.5 yrs {range 17 
5 1). 
O f the 90 paticms recruited, 86 paticms had visual acuity testing 
but 4 were too encephalopathic for testing. Seventy-four patients 
underwent VEP testing and 47 patients underwent H VF testing. 
Ten right eyes and 8 lcft eyes had absent VEP responses therefore 64 
right eyes and 66 left eyes were subj ected to quamita ti\·e VEP 
analysis for discre te latency and amplitude evaluation . H VF was 
done on 4 7 right eyes and 45lcft eyes. T he disparity was due to an old 
enucleation of one eye and post traumatic blindness in the other eye 
(fable 1). Sixteen paticms had profound , ·isual loss of < 6/ 60 on 
whom HVF could not be performed. The results of nash LED-
goggles VEP on 6 patients, who were unco-operatiYe, were not 
reproducible, too unreliable and not included for analysis. Only full 
field pattern reversal VEPs were included for analysis. 
While 40/ 86 (46.5%) patients had decreased best corrected 
visual acuity (BCVA), profound visual loss of < 6/60 was detected 
in 16/ 40 (40%) of those patients (19% in total). VEP was 
abnormal in 5 1/74 (68.9%) right eyes and 50/74 (67.6%) left eyes 
(fable 1). Of the 85 eyes with normal visual acuity, 48 (56.5%) had 
an abnormal VE P parameter ~atency and/ or amplitude). T he 
mean VEP P IOO latency was prolonged and l\80-P IOO amplitude 
reduced in both eyes when compared to our laboratory references. 
T he mean VEP P I 00 la tencies for the right and lcfi eyes were 
I 18.9 (:!: 16.5) ms a nd I 19.8 (:!: 15. 7) ms respectively, and for the 
l\'80-P IOO amplitude were 7.4 (:!:3.9) ~V and 7.0 (:!:3.7) ~V 
respectively. Our laboratory references for these parameters arc 
10+ (:!: 10) ms for VEP P IOO latency and 15 (:!:5) ~V for the l\80 
PIOO amplitude. i\ lcan la tency and amplitude differed significantly 
fi·om hospital references, p< O.OO I. A further breakdown of these 
abnormali ties show that the P I 00 latency alone was abnormal in 
55/ 130 (42.3%) eyes, the N80-PI 00 ampliwde alone was reduced 
in 19/ 130 {14.6%) eyes and together was abnormal in 9/ 130 
(6.9%) eyes (fable 2). 
HVF was abnormal in 36/4.7 (76.6%) right eyes and 32/ 45 
(71. I%) left eyes (fable I). Per ipheral constriction of the visual field 
and a la rge blind spot were the predominant defects, followed by 
central and paracentral scotomata, suggesting the greater impact by 
raised intracranial pressure over optic nerve infiltration (f igure I). 
Table 1. Freque ncies of Abno rmal VA, VEP and HVF. 
Visual 
acuity VEP VEP HVF HVF 
Right Left Right Left 
<616 Eye Eye Eye Eye 
N(%) N (%) N (%) N(%) N(%) 
Total 86 (100) 74 (100) 74 (100) 47 (100) 45 (100) 
Number 
Normal 46 (53.5) 23 (31. 1) 24 (32.4) 11 (23.4) 13 (28.9) 
Abnormal 40 (46.5) 51 (68.9) 50 (67.6) 36 (76.6) 32 (71.1 ) 
N - Number, VEP - Visual Evoked Potential, HVF - Humphrey's Visual Field. 
doi:l 0.1 371 /journa l.pone.005289S.t001 
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Table 2. VEP latency and amplit ude findings in 66 patients. 
Total f or Total for VA Total for VEP Latency and 
Amplitude VA Right Eye Right Eye VA Left Eye Left eye Combined (%) both eyes 
Normal Abnormal 
Normal Abnormal n = 64 Normal Abnormal n =66 n = BS n = 45 n = 130(100) 
Norm lat/ Norm amp 18 23 19 24 37 (78.7) 10 (21.3) 47 (36.2) 
Norm lat/Abn amp 11 8 16 (84.2) 3 (15.8) 19 (14.6) 
Abn !at/Norm amp 12 14 26 16 13 29 28 (50.9) 27 (49.1) 55 (42.3) 
Abn lat/Abn amp 4 (44.4) 5 (55.6) 9(6.9) 
Total Abn Latency 13 17 30 19 15 34 32 (50) 32 (50) 64 
Total Abn Amplitude 10 15 10 13 20 (71 .4) 8 (28.6) 28 
VEP - Visual Evoked Potential, VA - Visual Acuity, Norm - normal, lat - latency, amp - amplitude, Abn - abnormal. 
doi: 1 0.1371/ journal.pone.0052895.t002 
Significant correlations were noted benveen Visual Acuity and 
YEP latency of the right eye (p = 0.003) and YEP latency of the left 
eye (p = 0.03,) but not with YEP amplitude (fable 3). When 
BCVA was abnormal 17 /24 (70.8%) and 15 /21 (7 1.4%) of Y EP 
la tency was abnormal in the right and Jcf\ eyes respectively. \ Vhen 
BCYA was normal, 13 /40 (32.5%) and 19/45 (42.2%) of 
subclinical YEP latency abnormality was detected. VEP amplitude 
howc\·er did not hm·e a similar relationship, being normal in 19/ 
24 (79.2%) and 18/2 1 (85. 7%) of right and left eyes respectively, 
when BCYA was abnormal. Subclinical detection of VEP 
amplitude abnormality was detected in 10/4·0 (25%) and 10/45 
(22.2%) of the right and left eyes respectively. 
Swollen optic d isc was correlated with VEP PIOO la tency for the 
right and left eyes (p = 0.02, 0.047 resp.) but not with YEP 
amplitude. l\'o significant co rrelations were noted benveen CSF 
pressure and C D4eount with VEP latency a nd am plitude (T a ble 3). 
T able 4 demonstrates significa lll correla tion between VEP 
latency and HV F in both eyes (p= O.OO I , 0.0049). BCVi\ is 
co rrelated with HV F of the r ight eye, but not the lefi (p = 0.03 vs 
p = 0.5). \Vhilst this m ay reflect the impact of centra l scotomata on 
visua l acuity testing, figure I shows equal fi"equency of central 
scotomata in the right and left eyes. T herefore subclinical and 
asymm etrical optic nerve dysfunction is a possible explana tion. 




~ 14 .. 
12 .Q 
E 
10 " z 





Visual Field Defect 
the right and lef\ H V F were abnormal. Subcl inical H VF 
abnormality was on I)' detected in I I I I (9.1 %) and 2/ 13 (15.4%) 
of right and left eyes respectively. 
Discussion 
Cryptococcal induced visual loss can be devastating and, if 
neglected, irreversible [2 1] . Despite the easy availability of 
anti rctroviral therapy in son1c developing countries, the ncuro-
opthaJm ologicaJ complications of HIV infection and CJy ptococcal 
meningitis a rc still encountered. S tudies have shown that early and 
in tcnsiYC n1anagcn1cnt of raised intracranial pressure in C1I can 
reverse the visual loss associa ted with the disease [8,9]. Unfortu-
nately, due to the cnccphalopathic state of most patiems with C~ l 
and the lack of vig ilance by medica l personnel in emergency 
departments visual acuity is not tested or crude testing is done on 
admission. Ea rly detection of visual impa irment is therefo re m issed 
and tl1e window of opportunity to reverse optic nerve damage is 
often lost. 
T he first a im of this study was to detect the frequency of V EP 
and HVF abnormalities in patients with Ci\ I, correla te these 
fi ndings with visual acuity, thereby determining the presence of 
cli nical and subclinical d isease . The second aim was to determine 
if this unique VEP and H V F data could contribute to the optic 
• Right Eve 
• Left Eve 
Figure 1. Frequencies of Visual Field Defects. Constricted VF - Constricted Visual Field. 
doi:1 D.1371/journal.pone.0052895.g001 









































Table 3. Correlation between VEP and VA, CSF Pressure, Swollen optic disc and CD4 count in 66 patients. 
VEP Latency of Right Eye p value 
n = 64 
Normal Abnormal 
Visual Acuity Normal 27 13 0 .003 
(67.5%) (32.S%) 
Abnormal 7 17 
(29.2%) (70.8%1 
CSF Pressure Normal 11 9 0.9 
Elevated 21 18 
Sw ollen No 29 18 0.02 
optic disc 
-
Yes s 12 
CD4 count < 50 19 17 0.6 
50- 100 10 6 
101-1 99 
> 200 1 0 
VEP - Visual Evoked Potential, Visual Acuity refers to Best Corrected Visual Acuity. 
doi:l 0.1371 /journal.pone.0052895.t003 
VEP Latency of Left Eye p value 
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Table 4. Correlation between HVF and VA, CSF Pressure, Swollen opt ic disc, CD4 count and VEP in 47 patients. 
HVF of Right Eye p value HVF o f Left Eye P value 
n = 47 n = 4 5 
Normal Abnormal Normal Abnormal 
V isual Acuity Normal 10 0.03 11 0.5 
(90.9%) (9.1%) (84.6%) (15.4%) 
Abnormal 19 17 22 10 
(52.8%) (47.2%) (68.8%) (31.2%) 
CSF Pressure Normal 9 0.9 4 8 0.4 
Elevated 8 25 6 24 
Swollen optic d isc No 4 0.9 9 4 0.8 
Yes 22 13 20 11 
CD4 count < SO 4 19 0.7 4 18 0.14 
50- 100 9 6 
101- 199 0 0 
> 200 0 0 
V EP lat ency Normal 10 10 0.001 9 10 0.0049 
Abnormal 20 4 19 
VEP amplit ude Normal 6 0.1 6 0.1 
Abnormal 6 24 10 23 
HVF - Humphrey' s visual field, VEP - Visual evoked potential, Visual Acuity refers to Best Corrected Visual Acuity. 
doi:1 0.137 1/ jo urnal.pone.005289S.t004 
neuritis vs. papilloedema vs. companmelll syndrome debate 
SUITounding the pathogenesis of cryptococcal induced visual loss. 
Visual impairmem was detected in 40/86 (46.5%) of patiems 
with C~ l , and 16/40 (40%) had profo und visual loss of <6/60 
(19% in tota l). VEP abnormalities were detected more fi·cquently, 
occurring in 68.9% of right eyes and 67.6% of left eyes and 
subclinical disease in 56.5% (fables l and 2). T he predominant 
abnormal VE P parameter was prolongation of the P I 00 latency 
occurring in 42.3% of all eyes (table 2). T he mean PI OO latency 
values were I 18.9 (:!: 16.5) ms and 119.8 (:!: 15. 7) ms for the right 
and left eyes respccti,·cly, mildly prolonged when compared to our 
laboratory references of 104 (:!: 10) ms but still significant 
(p< O.OOI ). Prolonged P IOO latencies suggest demyelination or 
conduction block (focal demyelination), as occurs in acute optic 
neuritis which in the case of C~ l , a non-demyelinating disorder, 
will suggest focal pressure effects on the optic nerve. Conceivably 
the most likely sites of optic nerve compression will be at the optic 
canal or a t sites of dense subarachnoid trabeculae within the optic 
nerve sheath, prO\·iding soft evidence for the compartment 
syndrome in cryptococcal induced visual loss. 
VEP latency strongly correlated with ,·isual acuity and swollen 
optic disc; when VEP latency was prolonged , visual acuity was 
reduced and optic disc swelling occurred (fable 3). Such abnormal 
parameters provide strong clinical and electrophysiological 
evidence for optic nciYe dysfu nction in CI")1Jtococcal induced 
visual loss. T he fact that 32.5% and +2.2% of right and left eyes 
respectively with normal acuity had prolonged VEP latency is 
good e\·idence for subclinical optic nerve dysfunction. T he 
contribution to prolonged VEP latency made by the HI V virus 
in ad,·anccd H IV infection requires further evaluation. Claims of 
subclinical VEP abnormalities in 3--49% of HIV infected patients 
due to rctro-chiasmic or occipital cortical neuron loss have not 
been verified f 19,221. i\I wanza's group did not exclude CI)']ltO· 
PLOS ONE I www.plosone.org 5 
coccal meningitis and it is likely that the 49% includes patients 
with cryptococcal meningitis. In ~lalcssa's group of asymptomatic 
HIV-infccted patients, 3% had V EP latency prolongation and 
33% had VEP amplitude reduction when C D4 counts were below 
I 00. However in the scuing of co-infection with Ci\I, a nd noting 
the prominence played by the fu ngus in visual loss, one has to 
presume that a large amoum of the 56.5% of overall VEP 
abnormality (latency and amplitude) in our patients was due to 
CI")1Jtococcal co-infection rather than HIV alone (fable 2). A 
lim itation of this study is the fa ilure of comparison to an 
asymptoma tic HIV positive group without Ci\I to determine the 
impact if any of HIV infection itself. l\o signifi cam correlations 
were noted between VEP latency and CSF pressure or C D4 
counts (fable 3), possibly due to the relatively small number of 
patients recruited or that VEP and CSf pressure measurements 
were not always done at the same time. 
VEP amplitude changes occurred less frequently and this was 
the abnormality in only 14.6% of eyes suggesting that secondat)' 
axonal changes were not frequent despite the low mean ampliwdc 
of 7 . 1~ (:!:3 .9) f.LV and 7.0 (:!:3.7) f.L V for the right and left eyes 
respectively.(fable 2). The low frequency of amplitude changes 
may be a reflection of the somewhat early recruitment of patients 
from symptom onset (4 weeks). Perhaps repeat testing later in the 
disease n1ay reYeal more secondary iLxonal change, which is a late 
phenomenon. Consequently, no significant correlations were 
noted between VEP amplitude and visual acuity, CSf pressure, 
optic disc swelling or C D4 counts in early C M. (fable 2). 
HVF abnormalities were \"Ct)' frequent in patients who could be 
tested, occurring in 76.6% of right eyes and 7 1.1 % of left eyes. 
( f able l) A miljor limitation of HVF testing was that patients with 
profound , -isual loss (VA <6/60) could not be tested. T he 
predominant field defects " ·ere peripheral constriction with large 
blind spots followed by central and paracentral field defects. 





(Figure I) As periphera l constrictio n with large blind spots is 
associated with papilloedema-related optic nerve clysfi.mctio n, 
H VF supports raised intracranial pressure being an ll11portant 
cause of' o ptic nerve dysfi.mction in cryptococcaJ induced visua l 
loss. The cen tra l field defects fou nd suggest intrinsic optic nerve 
disease or secondary m acular clysfi.mction fi·om seve re pa pilloede-
ma; however an inability to test patiems with pro found ,·isual loss 
suggests that the ccmra l fi eld defect was proba bly underestimated 
in th is paticm cohort. 
HVF is also strongly correlated with VEP late ncy prolongation 
(p = 0.00 I righ t eyes and p = 0.0049 for left eyes) (fable 4 ). 
Subclinical HVF abnormalities were not as frequent as VEP 
late ncy abnormalities a nd arc therefore less sensitive in detecting 
optic nerve dysfunctio n in patients with norma l visual acui ty in 
C:\L 1\"o significa m correlations were no ted between HVF and 
C SF pressure, optic el ise swelling, C D4 coums or VEP amplitude . 
The VEP P IOO wa, ·e is easily recognized o n VEP testing and 
reproducible . T esting of cnccphalopathic patients was challeng ing 
in our cohort ofpatkms with C~ l. In patients who could be tcstrcl, 
VEP Pl OD latency was the predom inant abnormality and most 
strongly correlated with dccrcasccl visual acuity and optic disc 
swcUing. Furthermore, an apprecia ble numbe r o f paticms with 
norm al visual acuity clcmonstratecl P IOO late ncy prolongation 
suggesting subclinical disease and perhaps a cohort that require 
close 111onitoring and aggressive management of raised intracrania l 
pressure to JXCvcnt visua l loss. The contributio n to the PI 00 
latency prolongation m ade by HI V infectio n alon e needs further 
investigation . HVF defects were mostly co nsistent with ra ised 
intracranial pressure, even tho ugh patients with profound visual 
loss were unable to be tested. 
Prolongatio n o f the P I 00 latency in early C~ I lends some 
suppo rt for focal conduction block and hence the com partment 
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syndrome fi·o rn raised imracra nial pressure as a ca use fo r vis ua l 
loss in these patie nts. Papilloedema alone which occurs less 
fi·equently tha n visual loss docs no t accoum for most cases of ,·isua l 
loss, nei ther docs optic neuritis which is uncommon in the pauci-
infla mm awry Slate of Ci\1 in H lV infected patiellls r1 2l. The 
ncura praxia caused by the compression a t the optic canal o r 
o rbita l segment of the nctYe is po tentia lly re\-crsiblc by lower ing of 
intracra nial pressure rather than in1n1unosuppressant therapy as is 
used for idiopath ic optic neuritis rs,23]. 
\Vhile this study docs demo nstrate appreciable PIOO latency 
prolonga tio n c\·en in asympto ma tic Ci\1 paticms, the lo ng term 
implicatio n of th is result can only be answered by long itudina l 
swdics. VEP as a tool to predict visual loss in C~ ! is conce ivable 
a nd worth fu rther invest igatio n. Furthermo re, VEP and HVF 
provide clinical and subclinical c\·iclcncc fo r raised intracra nial 
pressure causing a possible compartme nt syndrome and optic 
neJYe dysfu nctio n. So can CSF pressure lower ing measures in 
additio n w oflc ring a n impro,·ccl overall prognosis prevent 
blindness in C~ I by prevention o f Lhe op tic nerve compartment 
syndrome rather than merely p reventing pa pilloedema? 
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CHAPTER 8 PAPER 5 
Optic nerve and Peri-optic CSF diffusion in Cryptococcal Meningitis, Optic Neuritis 
and Papilloedema: 
 
 This paper addresses aim 3.4 (especially 3.4.3) 
 A Moodley is the main author 
 The paper has been submitted to Journal of Neurological Sciences, and is awaiting 
review 
 
Twenty-nine healthy controls, 59 culture confirmed CM patients, 14 patients with 
papilloedema and 14 patients with optic neuritis from causes other than CM underwent 
magnetic resonance diffusion-weighted imaging and diffusion tensor imaging of the optic 
nerve and the peri-optic CSF. The apparent diffusion coefficient (ADC), fractional anisotropy 
(FA) and anisotropic index (AI) were compared among all 4 groups. 
Results: 
The AI of the peri-optic space (mean of 1.25) while less than that of the optic nerve (mean of 
1.85) was greater than that of the nearby vitreous (mean of 0.99) suggesting anisotropic 
diffusion within the peri-optic CSF. Hence, laminar rather than turbulent flow occurs within 
the peri-optic subarachnoid space (SAS). The papilloedema group alone showed lower AI of 
the peri-optic CSF than normal controls (1.3 vs. 1.1, and 1.2 vs. 1.1; p= 0.02 and 0.046 for 
the right and left eyes respectively). The optic neuritis group alone showed lower FA of the 
optic nerve than the control group (0.25 vs.0.41 respectively, p = 0.02) on the left side only. 
The FA in the peri-optic space was lower in the CM group with decreased vision than the 
control group (p = 0.03).  
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Optic nerve diffusion could not draw similarities between CM and papilloedema or optic 










Cryptococcal-induced visual loss is a devastating complication of cryptococcal meningitis 
(CM) despite antifungal therapy. There is no consensus regarding its pathogenesis and 
evidence for and against the optic neuritis and papilloedema theories abound in the literature.  
Method: 
Twenty-nine healthy controls, 59 culture confirmed CM patients, 14 patients with 
papilloedema and 14 patients with inflammatory/infective optic neuropathy (IION) from 
causes other than CM underwent magnetic resonance diffusion weighted imaging and 
diffusion tensor imaging of the optic nerve and the peri-optic CSF. The apparent diffusion 
coefficient (ADC), fractional anisotropy (FA) and anisotropic index (AI) were compared 
among all 4 groups. 
Results: 
The AI of the peri-optic space (mean of 1.25) while less than that of the optic nerve (mean of 
1.85) was greater than that of the nearby vitreous (mean of 0.99) suggesting anisotropic 
diffusion within the peri-optic CSF. Hence, laminar rather than turbulent flow occurs within 
the peri-optic SAS. The papilloedema group alone showed lower AI of the peri-optic CSF 
than normal controls (1.3 vs. 1.1, and 1.2 vs. 1.1; p= 0.02 and 0.046 for the right and left eyes 
respectively). The IION group alone showed lower FA of the optic nerve than the control 
group (0.25 vs.0.41 respectively, p = 0.02) on the left side only. The FA in the peri-optic 





Optic nerve diffusion could not draw similarities between CM and papilloedema or optic 





































































           Figure 2. Scatter Plots of ADC, AI and FA of the optic nerves 
 
ADC – Apparent Diffusion Coefficient, I – represents the eigenvector of diffusion along the nerve, FA – 
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            Figure 3 Scatter Plots of ADC, AI and FA of the peri-optic CSF 
 
ADC – Apparent Diffusion Coefficient, I – represents the eigenvector of diffusion along the nerve, FA – 
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Table 3.   ADC, Anisotropic Index and Fractional Anisotropy of the Optic Nerve 






 Right  Left Right Left Right Left 
Normal Control  1320 (463) 1380 (547) 0.46 (0.13) 0.41 (0.12)
a 
2.0 (1.5;2.7) 1.7 (1.4;2.0) 
CM with normal vision 1207 (412) 1387 (316) 0.41 (0.16) 0.42 (0.15) 1.5 (1.2;1.8) 1.6 (1.4;2.0) 
CM with decreased vision 976 (513) 1382 (359) 0.44 (0.11) 0.34 (0.08) 2.2 (1.4;2.6) 1.7 (1.4;2.0) 
CM with normal CSF 
pressure 
1117 (418) 1229 (239) 0.39 (0.17) 0.45 (0.16) 1.5 (1.4;2.3) 2.0 (1.6;2.6) 
CM with elevated CSF 
pressure 
1118 (498) 1407 (357) 0.43 (0.14) 0.38 (0.12) 1.5 (1.2;2.3) 1.6 (1.3;2.0) 
All CM patients 1116 (461) 1365 (339) 0.42 (0.14) 0.39 (0.13) 1.6 (1.4;2.3) 1.6 (1.4;2.0) 
Papilloedema 1354 (575) 1471 (433) 0.41 (0.15) 0.42 (0.11) 1.7 (1.3;2.7) 1.8 (1.3;2.3) 
Optic Neuritis  1451 (487) 1419 (589) 0.38 (0.13) 0.25 (0.02)
a 
1.5 (1.4;1.7) 1.6 (1.6;2.3) 
ADC – Apparent diffusion coefficient, SD – Standard Deviation, IQR – Interquartile range, CM – 







Table 4:  ADC, Anisotropic Index and Fractional Anisotropy of the Peri-optic SAS (CSF) 






 Right  Left Right Left Right Left 








CM with normal vision 2118 (356) 2081 (358) 0.30 (0.08) 0.32 (0.1) 1.2 (1.1;1.4) 1.3 (1.1;1.5) 




1.2 (1.1;1.5) 1.3 (1.1;1.4) 
CM with normal CSF 
pressure 
2078 (352) 2057 (248) 0.3 (0.12) 0.29 (0.13) 1.3 (1.0;1.4) 1.2 (1.1;1.4) 
CM with elevated CSF 
pressure 
2190 (378) 2073 (356) 0.27 (0.08) 0.28 (0.11) 1.2 (1.1;1.4) 1.3 (1.1;1.5) 
All CM patients 2196 (400) 2127 (360) 0.28 (0.09) 0.27 (0.11) 1.2 (1.1;1.4) 1.3 (1.1;1.4) 




Optic Neuritis 2260 (267) 2236 (417) 0.23 (0.07) 0.22 (0.07) 1.3 (1.1;1.3) 1.3 (1.2;1.3) 
ADC – Apparent diffusion coefficient, SD – Standard Deviation, IQR – Interquartile range, CM – 
Cryptococcal meningitis. a Significant difference between FA in Normal Control and CM with 













CHAPTER 9  PAPER 6 
The Optic Nerve Compartment Syndrome in Cryptococcal-induced Visual Loss: 
 This case report provides clinical support for the optic nerve compartment syndrome 
in CM induced visual loss 
 A Moodley is the main author 
 Published in Neuro-ophthalmology June 2013 
Visual loss in cryptococcal meningitis (CM) has been postulated to be due to papilloedema 
and/or optic neuritis. A 28 yr. old HIV positive female presented with visual loss, swollen 
optic discs and elevated CSF pressure due to CM.  CT cisternography and T2 MRI showed 
occlusion of the peri-optic CSF space and re-opening after serial lumbar punctures. 
Presumably lowering of the intracranial pressure resulted in equalization of pressure across 
the pressure gradient created by the fungal block. This case supports a third mechanism of 
visual loss in CM viz. an optic nerve compartment syndrome which seems more plausible as 
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Visual loss in cryptococcal meningitis (CM) occurs in 35% of patients [ 1]. The landmark study by 
Rex et al proposed 2 mechanisms of visual loss, an early optic neuritis model that occurs wi thin 6 
days of disease onset and a late papilloedema model that occurs after 4 weeks [2]. Since then, there 
have been many case reports supporting or contesting those claims [3-6]. The overwhelming evidence 
is that raised intracranial pressure, which occurs in up to 67% of patients, plays a role [I ,2]. Measures 
to lower intracranial pressure, such as serial lumbar punctures, ventriculoperitoneal shunts, Jumbo-
peritoneal shunts and optic nerve sheath fenestrations are all associated with improved visua l outcome 
[7-9]. However, papilloedema in patients with raised intracranial pressure occurs in only 22% of 
patients [1 ,2]. So papilloedema alone cannot be entirely responsible for the visual loss. While optic 
neuritis has been documented in histopathological cases, its occurrence too is infrequent. We have 
suggested the possibility of a compartment syndrome as being more common and the more likely 
mechanism responsible for visual loss in the setting of raised intracranial pressure by using diffusion 
weighted imaging of the optic nerve [1]. We postulate that the compartment syndrome develops from 
plugging of the peri-optic CSF space by funga l elements at the optic canal level or within the orbital 
segment of the nerve. The nerve compression at these si tes probabl y results in axoplasmic stasis and 
optic nerve dysfunction. 
Plugging of the peri-optic space by fungi and polysaccharide remnants is facilitated by the presence of 
septae, trabeculae and pillars within this space. Killer et al have demonstrated the presence of these 
anatomical structures within the peri-optic space whi ch are responsible for the compartmentalizat ion 
of the peri-optic CSF space from the intracranial subarachnoid space (SAS) [10]. They have 
postulated that these structures may account for idiopathic intracranial hypertension (ITH) wi thout 
papilloedema or asymmetrical papilloedema. We present a case that supports such a theory in CM, 
whi ch shares similar characteristics to IIH as regards raised intracranial pressure, impaired CSF re-




A 28 year old HTV positive black female, on antiretroviral therapy presented with culture confirmed 
CM. Her symptoms included headaches, blurred vision, neck pain and fever. Of note was that she had 
no pai n on eye movements and no dip lopia. She was awake, a lert and co-operative with minimal neck 
stiffness. Fundoscopy revealed bilateral swoll en optic di scs with peripapillary subreti nal 
haemorrhages (Figure 1). Her best corrected visual acuity (BCV A) was 6/ 18 OD and 6/ 12 OS, colour 
vision on Ishihara pseudoisochromatic p lates was 15/15 OU and her pupils were 3 mrn OU in ambient 
light and reactive to direct and consensual reflexes. Humphrey's visual fi elds demonstrated enlarged 
blind spots OU and nasal constriction OD (Figure 2). The rest of her crani al nerves, motor, sensory 
and co-ordination assessment were normal. Visual evoked potential (YEP) PlOO latencies were 
normal bi laterally (I ll ms OD and I 08ms OS). 
MRI brain was normal and MRI orbits showed no signal change within the optic nerve on hi gh 
resolution 3D T2 imaging (Figure 3, A and B). The peri-opti c CSF signal was absent bi laterally on the 
T2 imag ing. There was flattening of the posterior pole of the globe and opti c disc elevation bilatera ll y 
indicative of raised intracranial pressure. Post contrast T l SPIR (FAT Saturation) imaging showed 
optic nerve sheath enhancement (Figure 4). Her CD4 count was 181, CSF was acellular with normal 
biochemistry, CSF pressure was elevated at 37cmH20 and cryptococcal anti gen and India ink were 
posit ive. She had a macrocytic anaemia of 10.2 g/dl. Her vitamin Bl2 levels were normal suggesting 
that the macrocytosis was due to antiretroviral therapy. 
CT cisternography, performed via lumbar puncture, showed good contrast filling of the basal cisterns 
but stas is of the contrast loaded CSF at the distal optic nerve sheath before the optic canal (Figure 5). 
No contrast filling was noted to proceed beyond this block despite having the patient in a 
Trendelenburg position. She was managed with intraveno us Amphotericin B (0 .7mg/kg/d) for 2 
weeks followed by consolidation therapy with oral Fluconazole 400mg daily. Serial lumbar punctures 
were offered to reli eve the intracranial pressure which was normali zed after 3 lumbar punctures. At 8 
weeks follow up, her headaches bad completely cleared and BCV A improved to 6112 OD and 617.5 
OS. CSF pressure was noted to be normal before the repeat MRI which showed unblocking and re-




















































CHAPTER 10 DISCUSSION 
The qualitative and quantitative diffusion imaging of the optic nerve has proven to be a 
significant investigational tool in the imaging of optic nerve microstructure. In disease 
processes, most advances have been made in the imaging of chronic optic neuritis in multiple 
sclerosis and latterly in the imaging of acute optic neuritis [21, 22, 79, 112], ischaemic optic 
neuropathy [24] and glaucoma [86]. Hitherto, optic nerve diffusion imaging has never been 
applied to neuro-infectious disorders. With cryptococcal-induced visual loss being common 
in developing countries and noting that reversibility of blindness is possible with early 
intervention, we opted to use optic nerve diffusion to investigate the pathogenesis of CM 
induced visual loss. Consensus regarding the pathogenesis of CM induced visual loss has 
been lacking with good evidence for both the optic neuritis and papilloedema models 
reported in the literature. The likelihood of a dual mechanism has also been entertained but 
never demonstrated. The possibility of a third mechanism viz. the optic nerve compartment 
syndrome is also conceivable. Hence the motivation for this study was to establish if optic 
nerve diffusion imaging could provide new insights into the pathogenesis of CM induced 
visual loss.  
Testing of visual acuity is difficult in patients presenting acutely with CM for various 
reasons. Patients are confused, poorly attentive, systemically unwell, have raised intracranial 
pressure and frequently have 6th nerve palsies as false localizing signs. Despite these 
setbacks, we were able to demonstrate visual loss as a complication in 34.6% (18/52) of 
patients (reported in Chapter 4, Paper 1), similar to the incidence previously reported by 
Moosa et al [6]. All cases occurred within 4 weeks of disease onset and none after 
commencement of treatment. Severe visual loss occurred in 5 patients (9.6%), but none 
developed catastrophically within 12 hours as described by Rex et al in their series [10]. Such 
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visual loss was due to optic nerve infiltration/ neuritis. None of our patients complicated with 
optic nerve infiltration as demonstrated by clinical, radiological and electrophysiological 
means. Optic nerve infiltration as reported by Rex et al occurs early, so imaging within 4 
weeks of symptom onset was sufficient time to detect nerve infiltration [10]. 
Raised intracranial pressure was common, occurring in 69% (36/52) at an average of 
34cmCSF whereas disc swelling was noted in 25% of patients. Extremely high CSF pressures 
were noted in 7 patients at levels greater than 50cmCSF. Patients with decreased vision were 
more likely to have elevated CSF pressure and swollen discs; however only 44% had both, 
suggesting that elevated CSF pressure impairs optic nerve functioning, not predominantly at 
the optic nerve head, but somewhere between the lamina cribrosa and the optic canal. Despite 
elevated CSF pressure being common in CM, swollen optic discs is not as common (Figure 4, 
Chapter 4 Paper 1). Only twenty-three percent of all patients had both elevated pressure and 
swollen discs. The possibility of pressure related effects on the optic nerve exists, but not 
only at the optic nerve head. Whilst not entirely supporting the papilloedema model for vision 
loss this lends support for the compartment syndrome occurring somewhere along the nerve, 
either at the optic canal or the intra-orbital segment of the nerve.  
None of the CM patients scanned showed any optic nerve signal change on T1, T2, T2 
FLAIR or T1 post contrast image. The absence of signal change reflects a paucity of 
inflammatory reaction had there been any optic nerve infiltration by the organism, a situation 
that is reflected by minimal CSF changes in CM [6]. Conversely, the absence of signal 
change suggests that no infiltration of the optic nerve occurs by the organism or inflammatory 
cells and that an optic neuritis model does not occur in early CM to explain visual loss. Optic 
nerve infiltration by the organism does occur and is well documented but is not an early 
feature and not as frequent as reported by Rex et al [10, 11, 13]. 
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The lack of any significant difference between the optic nerve sheath diameter in the 
cryptococcal meningitis patients with and without elevated CSF pressure also supports the 
likelihood of a compartment syndrome (Table 2, Chapter 4 Paper 1). The lack of appreciable 
swelling of the optic nerve sheath in the presence of elevated CSF pressure as confirmed on 
lumbar puncture is possibly due to a blockage proximally at the rigid optic canal or 
somewhere along the intra-orbital optic nerve where septae in the subarachnoid space have 
created a blockage to CSF flow.  
In Paper 3, Chapter 6 MRI scanning has again been demonstrated to be an extremely 
sensitive imaging modality in the setting of central nervous system (CNS) cryptococcosis 
[48].  The overall percentage of presumptive cryptococcosis-related lesions on radiological 
findings is in line with results from the French case series [63% (55/87) vs. 79% (19/24) 
presumed cryptoccosis-related lesions, respectively] [48].  We detected significant numbers 
of patients with focal cerebral oedema [16% (14/87)]. No patients with generalised cerebral 
oedema were detected in the French series.  2% (2/87) patients had hydrocephalus versus 0% 
(0/24) in the French series, and we detected more cases of pseudocysts/cryptococcomas, 
radiological meningitis and infarcts [48]. 
In the case series of 87 patients, 20 (23%) patients had either cortical or lacunar infarcts that 
were presumed to be CNS cryptococcosis-related.  This finding is in keeping with recent 
Taiwanese data from immunocompetent patients where acute/subacute cerebral infarction 
(ASCI) occurred in 7/37 (20%) of patients [113].  Cerebral infarction, presumably related to 
some vascular, or perivascular inflammation, may not be uncommon in CM even in 
profoundly immunosuppressed patients with low CD4 cell counts.  
In this dataset, visual loss significantly correlated with the presence of presumed 
cryptococcosis-related lesions. Dilated VRS may indicate elevated CSF pressure. It is 
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difficult to determine the presence of brain swelling on a single brain scan in the context of 
late stage HIV-disease when significant but variable degrees of cerebral atrophy are present. 
We were particularly interested to see if paired initial and follow up scans suggested the 
presence of initial relative brain swelling in the first few days after presentation when any 
inflammatory response is likely to be maximal [114]. However, initial brain swelling was 
only identified in one patient on this basis.  Brain swelling may not be a common or 
significant factor in explaining the raised CSF pressure or abnormal mental status associated 
with CM.  However, in the study initial MRI scanning was carried out a median of seven 
days from patients starting antifungal therapy and it is conceivable that this was perhaps too 
late to detect early brain swelling that may have improved after initial antifungal therapy and 
appropriate management of CM complications such as raised ICP. 
In Chapter 7, paper 4 we report on 90 patients who were recruited for the electrophysiological 
study of CM induced visual loss. Visual impairment was detected in 40/86 (46.5%) of 
patients with CM, and 16/40 (40%) had profound visual loss of < 6/60 (19% in total). VEP 
abnormalities were detected more frequently, occurring in 68.9% of right eyes and 67.6% of 
left eyes and subclinical disease in 56.5% (Tables 1 and 2, Chapter 7 Paper 4). The 
predominant abnormal VEP parameter was prolongation of the P100 latency occurring in 
42.3% of all eyes (Table 2, Paper 4). The mean P100 latency values were 118.9 (±16.5) ms 
and 119.8 (±15.7) ms for the right and left eyes respectively, mildly prolonged when 
compared to our laboratory references of 104 (±10) ms, but still significant (p<0.001). 
Prolonged P100 latencies suggest demyelination or conduction block (focal demyelination), 
as occurs in acute optic neuritis which in the case of CM, a non-demyelinating disorder, will 
suggest focal pressure effects on the optic nerve. Conceivably the most likely sites of optic 
nerve compression will be at the optic canal or at sites of dense subarachnoid trabeculae 
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within the optic nerve sheath, providing soft evidence for the compartment syndrome in 
cryptococcal induced visual loss.  
VEP latency strongly correlated with visual acuity and swollen optic disc; when VEP latency 
was prolonged, visual acuity was reduced and optic disc swelling occurred (Table 3, Chapter 
7 Paper 4). Such abnormal parameters provide strong clinical and electrophysiological 
evidence for optic nerve dysfunction in cryptococcal induced visual loss. The fact that 32.5% 
and 42.2% of right and left eyes respectively with normal acuity had prolonged VEP latency 
is good evidence for subclinical optic nerve dysfunction. The contribution to prolonged VEP 
latency made by the HIV virus in advanced HIV infection requires further evaluation. Claims 
of subclinical VEP abnormalities in 3-49% of HIV infected patients due to retro-chiasmic or 
occipital cortical neuron loss have not been verified [115, 116]. Mwanza’s group did not 
exclude cryptococcal meningitis and it is likely that the 49% includes patients with 
cryptococcal meningitis. In Malessa’s group of asymptomatic HIV-infected patients, 3% had 
VEP latency prolongation and 33% had VEP amplitude reduction when CD4 counts were 
below 100. However in the setting of co-infection with CM, and noting the prominence 
played by the fungus in visual loss, one has to presume that a large amount of the 56.5% of 
overall VEP abnormality (latency and amplitude) in our patients was due to cryptococcal co-
infection rather than HIV alone (Table 2, Chapter 7 Paper 4). A limitation of this study is the 
failure of comparison to an asymptomatic HIV positive group without CM to determine the 
impact if any of HIV infection itself. 
VEP amplitude changes occurred less frequently and this was the abnormality in only 14.6% 
of eyes suggesting that secondary axonal changes were not frequent despite the low mean 
amplitude of 7.4 (±3.9) µV and 7.0 (±3.7) µV for the right and left eyes respectively (Table 2, 
Chapter 7 Paper 4). The low frequency of amplitude changes may be a reflection of the 
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somewhat early recruitment of patients from symptom onset (4 weeks). Perhaps repeat testing 
later in the disease may reveal more secondary axonal change, which is a late phenomenon. 
Consequently, no significant correlations were noted between VEP amplitude and visual 
acuity, CSF pressure, optic disc swelling or CD4 counts in early CM (Table 2, Chapter 7 
Paper 4). 
HVF abnormalities were very frequent in patients who could be tested, occurring in 76.6% of 
right eyes and 71.1% of left eyes (Table 1, Chapter 7 Paper 4). A major limitation of HVF 
testing was that patients with profound visual loss (VA < 6/60) could not be tested. The 
predominant field defects were peripheral constriction with large blind spots followed by 
central and paracentral field defects (Figure 1, Chapter 7 Paper 4). As peripheral constriction 
with large blind spots is associated with papilloedema-related optic nerve dysfunction, HVF 
supports raised intracranial pressure being an important cause of optic nerve dysfunction in 
cryptococcal induced visual loss. The central field defects found suggest intrinsic optic nerve 
disease or secondary macular dysfunction from severe papilloedema; however an inability to 
test patients with profound visual loss suggests that the central field defect was probably 
underestimated in this patient cohort.  
Subclinical HVF abnormalities were not as frequent as VEP latency abnormalities and are 
therefore less sensitive in detecting optic nerve dysfunction in patients with normal visual 
acuity in CM. No significant correlations were noted between HVF and CSF pressure, optic 
disc swelling, CD4 counts or VEP amplitude.  
Optic nerve diffusion imaging has gained prominence as a useful investigational tool of optic 
nerve microstructure and pathology [22, 81, 85].  We have opted to use both DWI and DTI to 
objectively examine the microstructure of the optic nerve in CM induced visual loss to obtain 
insights into its pathogenesis.  
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The technique used to scan the optic nerve was different to that of Wheeler- Kingshott’s 
zonal oblique multislice echo planar imaging (ZOOM-EPI) [33], Iwasawa’s IVIM [32] and 
Chabert’s non-CPMG FSE [34].  We used a higher B1000 gradient to eliminate CSF artifact 
rather than FLAIR, single shot fast spin echo to limit the effect of motion and a coronal 
oblique slice to image the optic nerves individually. By not using FLAIR, identification of the 
optic nerve on B0 images was made much simpler. The MD values reported for healthy optic 
nerves in the studies of Wheeler-Kingshott et al [33], Iwasawa et al [32] and Chabert et al [34] 
range between 1.0 and 1.3 x 10-3 mm2/s and FA range between 0.4 and 0.6. The method we 
used revealed comparable values of 1.2 ± 0.34 x 10-3 mm2/s for MD and 0.4 ± 0.12 for FA of 
healthy optic nerves. 
Optic nerve movement and CSF signal artifact still posed challenges to reliable imaging. In 
Chapter 5 Paper 2, we report on 29 healthy volunteers with intact visual acuity and eye 
movements that were subjected to DWI and DTI of the optic nerves. Optic nerve tracking 
was also done on 26 right eyes using single shot EPI FSE over a 3 minute period. Twenty still 
shots from nerve tracking were analysed and compared to diffusion data.  
Optic nerve movement distorts diffusion imaging of the optic nerve.  Six eyes had to be 
excluded from analysis due to poor visualization as a result of eye movement. Where analysis 
was possible, table 1 (Chapter 5 Paper 2) shows us that the results obtained were reliable. The 
ADC, MD, FA and AI of the optic nerve obtained in this study are comparable to those of 
Wheeler-Kingshott et al [33], Iwasawa et al [32]and Chabert et al [34](Table 1, Chapter 5 
Paper 2). The values for the peri-optic CSF space however are novel. The peri-optic CSF has 
a higher ADC and MD, and lower FA and AI indicative of the higher water content of the 
space. The greater isotropic diffusion is expected, but the AI > 1.0 seems to indicate laminar 
rather than turbulent flow of CSF in this space. As to whether there is bidirectional flow of 
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CSF within this space to allow return of the CSF back towards the brain [66] or unidirectional 
flow to the optic sheath cul-de-sac and extravasation into the orbit and optic nerve sheath 
lymphatics [111], cannot be determined from these data.  
Despite attempts at limiting optic nerve movement both voluntary and involuntary saccadic 
movements are unavoidable during a 3-5 minute DWI or DTI recording. Macroscopically, the 
optic nerve moves appreciably during a 3 minute recording. We recorded for our normal 
control group a mean of 11.8 mm (range 5.7 – 23.7) over a mean area of 5.2 mm2 (range 0.6-
22.1).  Fortunately, our data shows that optic nerve movement has no significant impact on 
optic nerve and peri-optic CSF diffusion parameters (Table 2, Chapter 5 Paper 2). Even more 
pleasing is the result that not suppressing the peri-optic CSF has no significant impact on 
optic nerve diffusion parameters on DWI and DTI. The advantage of not suppressing the CSF 
signal is better identification of the nerve on B0 images and the benefit of recording peri-
optic CSF diffusion parameters which can be applied to disorders such as papilloedema.  
Axonal disruption within the optic nerve following chronic optic neuritis is associated with 
an increase in ADC and a decrease in FA [22].  Whilst no significant difference in MD or FA 
was found between the elevated and normal CSF pressure groups in cryptococcal meningitis 
(graphs 1, 2 and table 3, Chapter 4 Paper 1), the tendency towards an elevated ADC and 
reduced FA suggests either axonal disruption in the elevated CSF pressure group or 
papilloedema related changes. In the acute setting where axonal degeneration is not expected, 
the latter seems more plausible. These findings lend support to the role played by elevated 
CSF pressure and papilloedema in early vision loss in CM. 
The similar anisotropy index in all pressure groups (Table 3, Chapter 4 Paper 1) and all 
vision groups (Table 4, Chapter 4 Paper 1) suggests that axial diffusion along the nerve is not 
preferentially affected in CM. Optic nerve infiltration therefore seems unlikely as a plausible 
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explanation for visual loss in early CM, contrary to the widely accepted theory of Rex et al 
[10].  This tendency towards increased ADC and reduced FA needs to be confirmed in future 
studies by recruiting larger number of patients, using 3T MRI which would offer higher 
resolution and by comparison to other causes of papilloedema.  
From 29 normal controls, 59 culture confirmed CM patients, 14 patients with papilloedema 
and 14 patients with optic neuritis (from causes other than CM) we were able to compare 
ADC, FA and AI obtained from the optic nerves and peri-optic CSF space. Paper 5 reports on 
their results. The numbers analysed were reduced due to movement artifact and difficulty 
encountered in identifying the optic nerve on DWI and DTI (Table 1, Chapter 8 Paper 5). 
The ADC of the peri-optic space is as expected much higher than that within the optic nerve 
due to the higher water content (Table 2, Chapter 8 Paper 5). The FA and anisotropic index of 
the optic nerve is greater than that of the peri-optic SAS due to the longitudinal orientation of 
the axons in the nerve that promote longitudinal diffusion in preference to radial diffusion. 
Not surprisingly, the peri-optic SAS too has an anisotropic index > 1.0 and mean FA of 0.29 
(both more than vitreous, p < 0.001), suggesting that the flow of CSF within this space is 
greater in the axial rather than the radial axis. Hence the suggestion of laminar rather than 
turbulent flow is demonstrated by this data. Laminar flow results from either the septae and 
trabeculae within the peri-optic space which provide some directionality to the flow of CSF 
or from the pressure gradient between the intracranial SAS and the peri-optic SAS or flow 
follows virtual channels created and obliterated as the nerve moves within its sheath as part 
of the physiological function of the moving eye. 
Figure 3 and Table 4 (Chapter 8 Paper 5) show a significant lowering of the anisotropic index 
of the peri-optic CSF space in the papilloedema group when compared to the normal controls 
(1.3 vs. 1.1, and 1.2 vs. 1.1; p= 0.02 and 0.046 for the right and left eyes respectively). The 
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lesser anisotropic (greater isotropic) diffusion in the setting of raised intracranial pressure 
suggests more turbulent flow of CSF in the peri-optic SAS. In the setting of raised 
intracranial pressure from CM, a similar lowering of the anisotropic index in the peri-optic 
SAS would be expected, but was not demonstrated in our cohort. The implication would be 
that the compartmentalization of the intracranial SAS from the peri-optic SAS was significant 
enough to prevent this effect. Fungal loading or even an excess of inflammatory cells within 
the peri-optic SAS would be expected to lower the anisotropic index in patients with CM and 
raised intracranial pressure, but this too did not occur. This finding together with the lack of 
dilatation of the peri-optic SAS in CM provides additional evidence for the compartment 
syndrome at the optic canal being the vital link between raised intracranial pressure and 
visual loss in CM. 
We have been able to demonstrate for the first time using DWI and DTI that CSF flow in the 
peri-optic SAS is laminar. CSF flow in the longitudinal plane was in preference to that in the 
radial plane. Such anisotropy would be expected to be lost in the setting of CSF loading by 
cryptococcal fungi and inflammatory cells. We were unable to confirm this regardless of 
whether patients had normal or elevated CSF pressure, normal or decreased vision. The 
likelihood of blockage upstream to prevent this cannot be refuted. Turbulent peri-optic CSF 
flow in the papilloedema group was not demonstrated in CM further suggesting that the 
pressure in the peri-optic SAS is not elevated. The compartmentalization described by Killer 
et al between the intracranial SAS and peri-optic SAS is possibly exacerbated by the fungal 
loading at the optic canal level resulting in a compartment syndrome. Unlike the hypothesis 
proposed by Killer et al of compartmentalization without blockage, we propose that with 
blockage created by fungal loading trapped between the trabeculae, there is a greater pressure 
gradient, lack of elevation of pressure beyond and perhaps lack of dilatation of the peri-optic 
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space beyond the blockage due to fungal loading in that space and drainage of whatever CSF 
remains into the surrounding lymphatics. 
Patients with CM did not demonstrate similar optic nerve or peri-optic SAS diffusion 
findings to that of optic neuritis or papilloedema regardless of their intracranial pressure and 
visual acuity. Raised intracranial pressure from causes other than CM does result in less 
anisotropic diffusion and more random diffusion of water molecules within the peri-optic 
SAS. The likelihood of greater compartmentalization between the intracranial SAS and peri-
optic SAS exists in CM that prevents the transmission of pressure to the peri-optic space with 
blockage perhaps from fungal entrapment at the optic canal. There is however sufficient 
pressure transmitted to result in papilloedema in 25% of patients, but insufficient to result in 
turbulent flow. Raised intracranial pressure (69 -90%) is far more common than papilloedema 
[10, 49] and possibly results in optic nerve dysfunction and visual loss from 
compartmentalization of the peri-optic SAS from the intracranial SAS rather than 
papilloedema itself.  
In Chapter 9 Paper 6, we present the case report of a 28 year old HIV positive female with 
CM induced visual loss. This case provides strong support for the optic nerve compartment 
syndrome as the mechanism underlying her visual loss. She presented with papilloedema and 
raised intracranial pressure from CM. There was complete obliteration of the peri-optic CSF 
space on MRI and CT cisternography showed blockage of flow of contrast loaded CSF into 
the distal orbital segment of the optic nerve. Lowering of intracranial CSF pressure and 
treatment with antifungal therapy resulted in re-opening of the peri-optic CSF space on MRI.  
A large pressure gradient was created by the blockage between the significantly elevated 
intracranial pressure within the intracranial SAS and the pressure of the proximal peri-optic 
SAS. A compartment syndrome thus followed causing optic nerve compression, axoplasmic 
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stasis and optic nerve dysfunction that manifest with visual blurring. Seemingly, the extent of 
axoplasmic stasis determines the presence of papilloedema which develops when stasis 
reaches the optic nerve head; a phenomenon that will explain the disparity between the 
frequencies of elevated intracranial pressure, visual loss and papilloedema in CM.  
This case provides good support for the compartment syndrome of the optic nerve in CM and 





 Visual loss is common in CM and occurs in 34.6 – 48% of patients 
 Raised intracranial pressure occurs in 69-71% of patients and the average intracranial 
pressure in CM was 34cmCSF (range 21-50) 
 Swollen optic discs occur in 25% of CM patients but 23% have swollen discs and 
raised intracranial pressure 
 No signal changes or contrast enhancement were noted in any of the optic nerves in 
patients with CM induced visual loss 




 Single shot EPI FSE, a b1000 gradient and lack of FLAIR are useful for limiting 
movement artifact and optic nerve identification on DWI and DTI 
 The coronal oblique method of separate nerve imaging on DWI and DTI is a reliable 
and reproducible diffusion technique 
 No significant correlation was noted between optic nerve movement parameters and 
diffusion parameters (ADC, MD, FA and AI) 
 The non-suppressed CSF signal on DWI and DTI has minimal impact on diffusion 
parameters of the optic nerve but none translates to practical or clinical significance. 
No mathematical model is required for correction as reflected by low R2 values on 
linear regression 
 63% of CM patients have neuroradiological lesions presumed to be cryptococcosis-
related.  
 21% of CM patients have additional treatable diagnoses on imaging 
 Visual loss correlated significantly with the presence of cryptococossis-related lesions 
on imaging 
 Paired imaging shows that brain swelling is not a common or significant factor in 
explaining the raised CSF pressure associated with CM 
 Subclinical VEP P100 latency prolongation occurs in 56.5% of CM patients 
 In patients with impaired vision, abnormal HVF is common (76% right eye, 71% left 
eye) and the predominant field defects are large blind spots with peripheral field 
constriction, consistent with raised intracranial pressure. 
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 VEP P100 latency is a useful screening test of subclinical optic nerve dysfunction. 
Subclinical HVF abnormalities are minimal and therefore HVF is a poor screening 
test 
 The ADC and MD of the peri-optic CSF space is higher and FA and AI of the peri-
optic CSF space is lower than that of the optic nerve 
 Laminar rather than turbulent flow exists within the peri-optic CSF space as suggested 
by an AI of 1.25. The AI of the optic globe is 0.99 suggesting isotropic diffusion and 
that of the optic nerve is 1.85 indicative of anisotropic diffusion. 
 Lower AI of the peri-optic CSF in papilloedema from other causes suggests decreased 
axial diffusion and perhaps increased turbulent flow. This was not reflected in CM 
patients with elevated intracranial pressure with papilloedema possibly due to 
compartmentalization of the peri-optic CSF space from the intracranial space 
 Optic nerve diffusion imaging could not draw similarities between CM and 
papilloedema or between CM and optic neuritis regardless of CSF pressure or vision 
 The evidence from the various papers presented suggests that optic neuritis in CM is 
uncommon and papilloedema does not correlate with visual loss. Raised intracranial 
pressure is common and visual loss is perhaps due to an optic nerve compartment 
syndrome. 
 The case report documents reversal of peri-optic CSF occlusion by lowering of 
intracranial pressure and 8 weeks of antifungal therapy is strong evidence for the optic 




CHAPTER 11 CONCLUSION 
Optic nerve diffusion imaging and electrophysiological testing of the optic nerve provide 
good evidence for an optic nerve compartment syndrome as the principal pathogenic 
mechanism of cryptococcal-induced visual loss. Fungal loading of the peri-optic CSF space 
cause plugging and blockage of the spaces between the trabeculae, septae and pillars of the 
subarachnoid space. A steep pressure gradient develops between the high pressure of the 
intracranial SAS and the peri-optic SAS which results in optic nerve compression, 
axoplasmic stasis and axonal disruption. Our case report shows this site of compression to be 
the distal orbital segment of the optic nerve; however the optic canal is another likely site due 
to its small diameter. Papilloedema is probably a secondary event that develops when 
axoplasmic stasis reaches the optic nerve head. Optic neuritis develops from a perineuritis or 
optic nerve extension of the cryptococcal meningo-encephalitis, but is an infrequent 
occurrence. 
We therefore recommend vigilant CSF pressure monitoring early during CM and alleviation 
of elevated CSF pressure to prevent blindness. Optic nerve sheath fenestration has been 
shown to be useful but is not readily available in most developing countries and rural areas. 
Lumbar peritoneal shunts and ventriculoperitoneal shunts are prone to displacement and 
secondary infection. Serial lumbar puncture while uncomfortable to the patient remains a 








CHAPTER 12: LIMITATIONS AND FUTURE RESEARCH 
 
Limitations of the Study 
1. Patients recruited had to be co-operative for electrophysiological testing and MRI 
scanning (which took about an hour). Selection bias might have been introduced as 
comatose patients were excluded. 
2. It was not possible to do CSF pressure measurement and MRI scanning on all patients 
on the same day. However correlations were made between them.  
3. Eye and optic nerve movement could not be avoided in all cases between B0 and 
B1000 diffusion gradients. 
4. MRI scanning was done within 2 weeks of treatment commencement which might 
have influenced imaging features such as cerebral oedema. 
5. Even though 14 patients with optic neuritis were recruited, diffusion data could only 
be analysed in 6 patients due to movement artifact and difficulty in locating the nerve 
on DWI and DTI. 
6. Visual field testing was not done on HIV positive patients without CM for 
comparison. Such data was relied upon from the literature. 
7. Optic nerve tracking was not done at the same time as DWI and DTI but immediately 






1. The possibility of the compartment syndrome needs to be explored further. A CT 
cisternography study comparing the peri-optic CSF filling of contrast loaded CSF in 
CM patients with normal and elevated CSF pressure needs to be investigated. 
2. Study a larger cohort of CM patients using 3T MRI to determine if the higher ADC 
and reduced FA is verifiable in CM with elevated CSF pressure 
3. An Optical Coherence Tomography Study that documents the degree of optic disc 
oedema in CM patients and follow up during treatment with comparison of CSF 
pressure. LP’s (CSF pressure measurement) and optical coherence tomography can be 
done pre-treatment, at 4 weeks and at 10 weeks.  
4. A long term follow-up study of survivors to determine visual outcome in patients 
treated with pressure lowering measures and those without.  
5. A study to determine the incidence of hearing loss in CM and an MR imaging study 
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In South Africa, Cryptococcal meningitis is a common opportunistic infection in severely 
immunocompromised HIV infected patients. The antiretroviral rollout program has not yet 
had an impact on the incidence of cryptococcal meningitis due to limited access to ARV 
rollout sites and restrictions imposed on the number of patients eligible for treatment. 
Cryptococcal meningitis presents as an AIDS - defining illness in 84% of patients and 50 % 
of patients present with neurological complications (Moosa YM et al). One such 
complication is visual loss due to optic nerve disease which is reported in 52.6% of patients 
with cryptococcal meningitis. Vision loss continues to deteriorate in 17.3% despite antifungal 
therapy and in 3.7% of patients follows commencement of antifungal therapy (Seaton et al, 
1997). So despite antifungal therapy vision may continue to deteriorate and recovery is 
unpredictable. Early and effective adjunctive therapy is therefore of paramount importance to 
prevent or reverse the frequent and sometimes catastrophic loss of vision.  
 
Appropriate interventional therapy can only be identified once the pathophysiology of vision 
loss in cryptococcal meningitis is well understood. Unfortunately, there are conflicting 
reports regarding its pathophysiology and standard treatment protocols are disappointingly 
lacking. 
 
An inflammatory (optic neuritis) model is supported by visual improvement with 
corticosteroid therapy in cryptococcal induced vision loss (Seaton RA et al), the 
demonstration of active inflammation and necrosis of the optic nerve without vascular 
infiltration but florid infiltration of the surrounding meninges by the cryptococcal organism 
(Cohen DB, 1993) and centrocaecal scotomata on visual field testing (Lipson BK et al). On 
the other hand, a raised intracranial pressure (papilloedema) model is suggested by the 
beneficial response to serial lumbar punctures, ventriculoperitoneal shunts and lumbar 
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peritoneal shunts on cryptococcal induced vision loss (Ferreira RC et al 1997, Clauss JJ 
1998) and the accompanying constricted visual fields and enlarged blind spot in these 
patients. 
  
The mechanism by which patients with cryptococcal meningitis develop visual loss continues 
to be unclear with anecdotal evidence supporting opposing theories of papilloedema and optic 
neuritis. These theories may not be mutually exclusive and a mechanism that incorporates 
both theories is also conceivable. Pathological studies and in vitro studies (rat optic nerve) are 
scanty and can be misleading due to the loss of the effects of raised pressure on the optic 
nerves post mortem. An in vivo study that investigates the pathogenesis of optic nerve 
dysfunction in cryptococcal induced visual loss is therefore necessary. 
 
Diffusion weighted imaging (DWI) of the optic nerve has been shown to be of benefit in 
differentiating acute from chronic neuritis in Multiple Sclerosis (Iwasawa T, 1997, Wheeler-
Kingshott, 2002). Apparent diffusion coefficient (ADC) values are obtainable on normal 
optic nerves and can be compared to pathological conditions. Qualitative mapping and 
quantitative data can be obtained on diffusion imaging. Diffusion of protons within optic 
nerves is anisotropic due to the orientation of fibres. Hence diffusion that occurs parallel to 
the axons is greater than that which occurs perpendicular. This parallel to perpendicular ratio 
is disrupted in the presence of inflammation and demyelination and becomes less anisotropic 
or more isotropic. The demonstration of anisotropic diffusion is achieved with DWI obtained 
separately in orthogonal directions or by Diffusion tensor imaging (DTI).  
ADC values from DWI can be obtained in different orthogonal directions and compared. 
Such comparison will allow for an evaluation of the degree of anisotropic diffusion. 
Fractional Anisotropy obtained from DTI also provides a quantitative assessment of 
anisotropic diffusion. Comparative assessments of anisotropy as established by DWI and DTI 
can be done between patients with cryptococcal induced visual loss and control subjects. 
 
In optic neuritis, there is perivascular lymphocytic infiltration, multifocal demyelination, and 
reactive astrocytosis (Ergene E, 2004). Iwasawa T et al have demonstrated decreased 
diffusion in acutely inflamed optic nerves with reduced ADC values but no comparisons were 
made between perpendicular and parallel diffusion. One may hypothesize a similar diffusion 
abnormality of the optic nerves in cryptococcal induced visual loss if the predominant 
disorder is optic nerve infiltration. In the optic neuritis model, the ADC values along the 
parallel plane will be decreased and Fractional Anisotropy values will also be reduced due to 
the presence of inflammatory cells and fungi. One may also expect a decrease in the parallel 
to perpendicular diffusion ratios and Fractional Anisotropy should decrease due to greater 
isotropic diffusion.  
 
In papilloedema from any cause of elevated intracranial pressure, disc swelling results from 
axoplasmic flow stasis. There is entrapment of the optic nerve axons at the lamina cribrosa 
due to elevated intracranial pressure transmitted along the subarachnoid space to the junction 
of the globe and retrobulbar optic nerve. Axoplasm and metabolic products accumulate at the 
optic disc resulting in hyperaemia and elevation of the disc. The retrobulbar optic nerve is 
structurally normal in papilloedema but little is known about its functional status. In any 
liquid medium, diffusion of molecules is dependent on the thermal energy of the medium. 
When thermal energy increases, there is increased kinetic energy and increased diffusion of 
molecules. Therefore one may speculate that the effect of elevated pressure on the optic nerve 
as occurs in papilloedema, will result in increased thermal motion of the water molecules and 
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therefore increased diffusion. Higher ADC values will occur in both the parallel and 
perpendicular directions. The ratio of parallel to perpendicular diffusion should be maintained 
since diffusion will be increased in both planes. One may also speculate that the Fractional 
Anisotropy of diffusion along the optic nerve should be unchanged. 
 
Hence, DWI and DTI could theoretically be useful measuring instruments to differentiate 
between the effects of raised pressure and infiltration on optic nerve functioning. The 
possibility of dual mechanisms will also be entertained and explored.  
 
The aim of the study is to investigate the pathogenesis of cryptococcal induced visual loss by 
the use of DWI in vivo. The initial goal will be to clinically and electrophysiologically 
describe visual loss in patients with cryptococcal meningitis. Concurrently, the techniques of 
Diffusion and Diffusion Tensor imaging of the optic nerve will be optimized and made 
reproducible for reliable testing of subjects and controls. Techniques that have already been 
employed (Iwasawa T 1997, Wheeler-Kingshott 2002) will need modification to 
accommodate the restricted resources available and imaging of mildly confused patients. The 
modifiable parameters that will be considered are movement artifact, fat suppression, fluid 
attenuation, ‘b’ values etc to optimize signal to noise ratio (SNR).  
 
Comparisons will be made to normal controls, patients without visual loss, and to patients 
with pathophysiologically established causes of papilloedema and optic neuritis. Such 
comparisons will support either a papilloedema or optic neuritis model. The benefit of such 
information will be realized in guiding appropriate treatment strategies to either lower 
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1. To clinically, electrophysiologically and biochemically describe optic nerve 
dysfunction in cryptococcal induced visual loss according to  
1.1 Frequency of visual disturbance 
1.2 Severity of visual disturbance 
1.3 Mode of onset of vision loss 
1.4 Relationship to degree of immunopsuppression and treatment 
1.5 CSF findings 
 
 
2. To optimise Diffusion-weighted (DWI) and Diffusion tensor (DTI) imaging of the 
optic nerve and thereby obtain standard and reproducible imaging protocols. 
 
 
3. To devise a mathematical model that separates optic nerve diffusion from surrounding 





4. To propose a probable pathogenesis of Cryptococcal induced visual loss by 
investigating and comparing the following 
 
 
 Quantitative DWI and DTI of the optic nerves in patients with cryptococcal induced 
visual loss, using protocols obtained in Aims 2 and 3 above and comparing to normal 
controls. 
 
 Comparison of routine FSE, DWI and DTI of the optic nerves in patients with 
cryptococcal meningitis stratified into 2 groups with normal and abnormal visual acuity. 
. 
 Comparison of FSE, DWI and DTI of the optic nerves in patients with cryptococcal 
induced visual loss, to patients with papilloedema (IIH, malignant HPT and RICP) and optic 








Informed consent will be obtained from all patients and controls included in the study. 
Patients will be recruited from Grey’s Hospital, Edendale Hospital and Northdale Hospital. 
Prior ethics approval will be obtained from the University of Kwazulu Natal and support 
obtained from management and clinician heads at the above institutions as well as approval 





Sequentially select 100 patients with cryptococcal meningitis and normal mental state. 
Conduct the following tests on these patients; 
 Visual Acuity testing 
 Visual Field testing 
 Fundal photography 
 Visual evoked potentials 
 Neurological Examination including pupillary reflexes 
 CD4 count and Viral load 
 CSF examination- MCCS, India Ink, Cryptococcal antigen, FTA, Cysticercosis Elisa, 
CSF opening pressure. These tests will be performed as routine investigations on patients. 
Patients will be excluded if these tests were not done as standard management. 







Perform the following MRI tests on 20 normal controls; 
 
2.1 FSE of the optic nerves, pre and post contrast on coronal and axial planes 
2.2 High resolution T2 W of optic nerve and measure optic nerve sheath diameter 
2.3 DWI of the optic nerves on axial and coronal planes. 
ADC values obtained at 3 sites along the Nerve and its surrounding CSF. 
2.4 Three ‘ b values’ will be used and ADC values obtained in 6 directions 
2.5 ADC values will be obtained from the basal cisterns and optic chiasma on 






      




Perform the following on 20 patients with cryptococcal meningitis without vision loss and 20 
patients with vision loss; 
4.1 FSE of the optic nerves, pre and post contrast on axial and coronal                    
planes 
4.2 High resolution T2 W axial imaging of the optic nerves and measure optic nerve 
sheath diameter 
 
4.2 DWI and DTI of the optic nerves, optic chiasma and basal cisterns on axial and 
coronal planes. Obtain ADC values as previously outlined. 
 
 
Perform the following on 10 patients with papilloedema and 10 patients with optic neuritis 
from any cause excluding cryptococcal meningitis, 
 
4.3 FSE of the optic nerves, pre and post contrast on axial and coronal planes 
4.4 High resolution T2 W axial imaging of the optic nerves and measure optic nerve 
sheath diameter. 
4.5 DWI and DTI of the optic nerves, optic chiasma and basal cisterns on axial and 





















   
